2021-12-16T15:11:36-06:00 2021-06-30 366055558 GRANT THORNTON LLP 171 N CLARK ST SUITE 200 CHICAGO IL 60601 990 2020-07-01 133039601 ALZHEIMER'S DISEASE & RELATED DISORDERS ASSOCIATION INC ALZH 3123358700 225 N MICHIGAN AVE 17TH FLOOR CHICAGO IL 606017633 RICHARD HOVLAND COO, CFO, & ASST. TREASURER 2026388660 2021-12-16 1 RICHARD HOVLAND XXX-XX-XXXX BRIDGET ROCHE P00666837 3128560200 3 AAL1 IAL1 2020 2022-09-23 18:48:47Z ALZHEIMER'S ASSOCIATION RICHARD HOVLAND 225 N MICHIGAN AVE 17TH FLOOR CHICAGO IL 606017633 432720077 0 X WWW.ALZ.ORG X 1980 DE THE ALZHEIMER'S ASSOCIATION LEADS THE WAY TO END ALZHEIMER'S AND ALL (CONTNUED IN SCHEDULE O) OTHER DEMENTIA - BY ACCELERATING GLOBAL RESEARCH, DRIVING RISK REDUCTION AND EARLY DETECTION, AND MAXIMIZING QUALITY CARE AND SUPPORT. 29 29 2405 29606 0 0 381002937 377428810 7070398 3318234 10240491 16168267 4773180 7611330 403087006 404526641 51905028 66455349 0 0 190548712 181604398 1591733 1642050 63534624 143762020 115849579 387807493 365551376 15279513 38975265 410346682 497643896 134071218 142547117 276275464 355096779 X THE ALZHEIMER'S ASSOCIATION IS THE LEADING VOLUNTARY HEALTH ORGANIZATION IN ALZHEIMER CARE, SUPPORT, AND RESEARCH. (MISSION CONTINUED IN SCHEDULE O) 0 0 194977876 2120417 2901125 SEE SCHEDULE O 67939228 57685833 376826 SEE SCHEDULE O 3668724 CHAPTER SERVICES - APPROXIMATELY 200 OFFICES ACROSS THE U.S. ARE DOING BUSINESS AS THE ALZHEIMER'S ASSOCIATION AND VARIOUS NAMES AS A COLLECTION OF 75 CHAPTERS OF THE ASSOCIATION AND ARE IN COMMUNITIES NATIONWIDE PROVIDING SERVICES TO FAMILIES AND PROFESSIONALS INCLUDING: INFORMATION AND REFERRAL, SUPPORT GROUPS, CARE CONSULTATION, AND EDUCATION AND SAFETY SERVICES. 20055396 6649099 40283 OTHER PROGRAM SERVICESADVOCACY - AS ALZHEIMER'S DISEASE THREATENS TO BANKRUPT FAMILIES, BUSINESSES AND OUR HEALTHCARE SYSTEM, SCIENTISTS ARE MOVING CLOSER TO FINDING BETTER TREATMENTS THAT COULD ALTER THE COURSE OF THE DISEASE. THE ALZHEIMER'S ASSOCIATION ADVOCATES FOR PUBLIC POLICIES AIMED AT ADVANCING RESEARCH TOWARD BETTER THERAPIES, DETECTION, METHODS OF PREVENTION AND ULTIMATELY A CURE, AS WELL AS FOR BETTER CARE AND RESOURCES, AND HEALTH AND LONG-TERM COVERAGE TO ENSURE HIGH QUALITY COST EFFECTIVE CARE FOR PEOPLE WITH ALZHEIMER'S DISEASE AND THEIR FAMILIES. MORE THAN 600,000 GRASS ROOTS ALZHEIMER'S ASSOCIATION ADVOCATES SPEAK UP FOR THE NEEDS AND RIGHTS OF PEOPLE WITH ALZHEIMER'S AND THEIR FAMILIES, AND ENCOURAGE CONGRESS TO INCREASE FUNDING FOR RESEARCH AND CARE. ADVOCACY ACTIVITIES ALSO INCLUDE COLLABORATING WITH OTHER ORGANIZATIONS TO IMPROVE QUALITY CARE AND RAISE AWARENESS OF KEY ISSUES. CARE, SUPPORT, AND RISK REDUCTION - THE ALZHEIMER'S ASSOCIATION* PROVIDES AN ARRAY OF INFORMATION AND SUPPORT SERVICES DESIGNED SPECIFICALLY FOR INDIVIDUALS WITH ALZHEIMER'S DISEASE, THEIR FAMILIES, FRIENDS AND CAREGIVERS. IN ORDER TO MEET THE DIVERSE NEEDS OF INDIVIDUALS AFFECTED BY ALZHEIMER'S DISEASE, THE ASSOCIATION'S PROGRAMS AND SERVICES ARE OFFERED IN PERSON, BY PHONE AND ONLINE. IN CHAPTERS THROUGHOUT THE COUNTRY, CONSTITUENTS CAN ATTEND EDUCATION PROGRAMS AND SUPPORT GROUPS, RECEIVE PERSONALIZED CARE CONSULTATION, ENGAGE IN EARLY STAGE PROGRAMS, AND ENROLL IN SUPPORT PROGRAMS. IN ORDER TO MEET THE NEEDS OF CONSTITUENTS WHO RELY ON THE WEB FOR INFORMATION AND SUPPORT, THE ASSOCIATION OFFERS A ROBUST CAREGIVER CENTER. WITHIN THE CAREGIVER CENTER, FAMILIES AND CAREGIVERS CAN ACCESS ALZHEIMER'S NAVIGATOR*, AN INNOVATIVE TOOL TO HELP CAREGIVERS AND PEOPLE WITH DEMENTIA EVALUATE THEIR NEEDS, CREATE A CUSTOMIZED ACTION PLAN AND LINK TO INFORMATION, SUPPORT AND LOCAL RESOURCES FOR INDIVIDUALS LIVING WITH ALZHEIMER'S. ALSO AVAILABLE THROUGH THE CAREGIVER CENTER, FOR INDIVIDUALS LOOKING FOR SUPPORT FROM OTHERS LIVING IN SIMILAR SITUATIONS IS ALZCONNECTED*, AN ON-LINE COMMUNITY THAT INCLUDES MULTIPLE FORUMS FOR DIVERSE AUDIENCES.THROUGH THE ASSOCIATION'S HELPLINE, AVAILABLE 24 HOURS A DAY, 7 DAYS A WEEK, 365 DAYS A YEAR, INDIVIDUALS WITH ALZHEIMER'S DISEASE, THEIR FAMILIES AND CAREGIVERS CAN TALK TO A SPECIALIST TO RECEIVE INFORMATION AND BASIC EDUCATION ABOUT THE DISEASE; AND GUIDANCE FOR MORE COMPLICATED OR URGENT SITUATIONS, WITH MASTERS-LEVEL COUNSELORS WHO ARE AVAILABLE TO CONSTITUENTS, ANY TIME, DAY OR NIGHT. ADDITIONALLY, CALLS CAN BE HANDLED IN OVER 170 DIFFERENT LANGUAGES THROUGH THE USE OF A PROFESSIONAL LANGUAGE LINE. ANNUALLY, THE HELPLINE RECEIVES APPROXIMATELY 300,000 CALLS.THE ASSOCIATION'S WEBSITE (WWW.ALZ.ORG*) RECEIVES MORE THAN 37 MILLION PAGEVIEWS A YEAR. ONLINE PROGRAMS INCLUDE: SELF-SERVICE EDUCATION PROGRAMS, AN ONLINE COMMUNITY, AN INTERACTIVE BRAIN TOUR (AVAILABLE IN 15 LANGUAGES), ACCESS TO COMPREHENSIVE DISEASE INFORMATION, PORTALS IN SPANISH, CHINESE, VIETNAMESE, JAPANESE, AND KOREAN; A VIRTUAL LIBRARY, A SAFETY CENTER, AND A SECTION DEVELOPED SPECIFICALLY FOR PEOPLE LIVING WITH ALZHEIMER'S, WITH INPUT FROM PEOPLE IN THE EARLY STAGES OF ALZHEIMER'S DISEASE AND THEIR CARE PARTNERS. THROUGH THE ASSOCIATION'S EARLY STAGE INITIATIVE, INDIVIDUALS IN THE EARLY STAGES OF THE DISEASE CAN PARTICIPATE IN EDUCATION PROGRAMS, SUPPORT GROUPS AND SOCIAL ENGAGEMENT PROGRAMS. ADDITIONALLY, THE ASSOCIATION CONVENES AN EARLY STAGE ADVISORY GROUP WHOSE MEMBERS RAISE AWARENESS, ADVOCATE FOR THE CAUSE, AND PROVIDE GUIDANCE AND REVIEW OF PROGRAMS AND SERVICES.THE ALZHEIMER'S ASSOCIATION HAS LAUNCHED AN INITIATIVE TO WORK WITH HEALTH SYSTEMS, LONG-TERM CARE FACILITIES, AND COMMUNITY-BASED DEMENTIA PROVIDERS WITH EVIDENCE-BASED INFORMATION AND QUALITY IMPROVEMENT PROGRAMMING TO ENHANCE HOW THESE SYSTEMS PROVIDE CARE AND SUPPORT SERVICES. UNIQUE PROGRAMMING OPPORTUNITIES INCLUDE DIRECT TRAINING TO PROVIDERS, QUALITY IMPROVEMENT INITIATIVES AND VIDEO-BASED EDUCATION THROUGH PROJECT ECHO. THE PROGRAMS AND SERVICES OF THE ALZHEIMER'S ASSOCIATION ARE DESIGNED TO PROVIDE EDUCATION, INFORMATION, SUPPORT, AND RESOURCES IN ORDER TO HELP INDIVIDUALS WITH ALZHEIMER'S, THEIR FAMILIES AND CAREGIVERS NAVIGATE THE LONG AND COMPLICATED JOURNEY THROUGH ALZHEIMER'S DISEASE AND OTHER DEMENTIAS.* THESE ARE NAMES THAT ARE TRADEMARKS TO ALZHEIMER'S ASSOCIATION. 20055396 6649099 40283 286641224 1 1 0 1 0 0 0 0 0 1 1 1 0 0 1 1 0 1 0 0 1 1 0 1 1 0 0 1 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 1 1 0 1 931 0 1 2405 1 0 0 0 0 0 1 1 0 0 0 0 0 0 X 29 29 0 0 0 0 0 0 0 1 1 0 1 1 1 1 1 1 1 1 1 1 0 AL AK AZ CA CT DC FL GA IL KS KY ME MD MA MI MN MS NH NJ NM NY NC OK OR PA RI SC TX UT VA WA WV WI X X X RICHARD HOVLAND COO CFO & ASST TREASURER 3123355771 225 N MICHIGAN AVE 17TH FLOOR CHICAGO IL 606017633 HARRY JOHNS PRESIDENT & CEO 60.00 0.12 X 805616 3144 211246 DONNA MCCULLOUGH CHIEF FIELD & DEVELOP. OFFICER 60.00 0.00 X 701034 0 58694 KATHERINE JOANNE PIKE CHIEF STRATEGY OFFICER 60.00 0.02 X 620802 223 94144 RICHARD HOVLAND COO & ASST. TREAS. 60.00 0.06 X 600404 902 92090 MARIA CARRILLO CHIEF SCIENCE OFFICER 60.00 0.00 X 543657 0 94618 ROBERT EGGE CHIEF PUBLIC POLICY OFFICER 60.00 0.58 X 525571 8171 89924 GLENDA BERRY WEST AREA LEADER 60.00 0.00 X 470947 0 76366 KENANN CASSIDY EAST AREA LEADER 60.00 0.00 X 474322 0 67981 MICHELLE HELTON CHIEF FINANCIAL OFFICER 60.00 0.00 X 364136 0 64747 CHRISTINE FOH ASST. SECY. & VP LEGAL & GC 60.00 0.04 X 274848 305 36457 BRIAN RICHARDSON CHAIR AND DIRECTOR 12.00 0.50 X X 0 0 0 DAVID GOLTERMANN CHAIR AND DIRECTOR (THRU 10/2020) 12.00 0.50 X X 0 0 0 CECILE PERICH VICE CHAIR AND DIRECTOR 12.00 0.00 X X 0 0 0 ANNA CATALANO SECRETARY AND DIRECTOR (THRU 10/2020) 10.00 0.00 X X 0 0 0 RYAN MUNDY SECRETARY AND DIRECTOR 10.00 0.00 X X 0 0 0 JULIA WALLACE TREASURER AND DIRECTOR 10.00 0.00 X X 0 0 0 ALEX TSAO DIRECTOR 5.00 0.00 X 0 0 0 ANDREW DAHLKEMPER DIRECTOR 5.00 0.00 X 0 0 0 ARTHENA CASTON DIRECTOR (AS OF 10/2020) 5.00 0.00 X 0 0 0 BRUCE BAUDE DIRECTOR 5.00 0.00 X 0 0 0 BRUCE LAMB DIRECTOR (AS OF 10/2020) 5.00 0.00 X 0 0 0 CAROLYN TIEGER DIRECTOR (THRU 10/2020) 5.00 0.00 X 0 0 0 CYNTHIA LEMERE DIRECTOR (THRU 10/2020) 5.00 0.00 X 0 0 0 DAVID GONZALES DIRECTOR (AS OF 10/2020) 5.00 0.00 X 0 0 0 DAVID HUNTER DIRECTOR 5.00 0.00 X 0 0 0 DEAN BRENNER DIRECTOR (AS OF 10/2020) 5.00 0.00 X 0 0 0 DEBRA PIERSON DIRECTOR 5.00 0.00 X 0 0 0 DEREK VAN AMERONGEN DIRECTOR 5.00 0.00 X 0 0 0 EILEEN KAMERICK DIRECTOR 5.00 0.00 X 0 0 0 GEOFF HEREDIA DIRECTOR 5.00 0.00 X 0 0 0 GEORGE JOHNSON DIRECTOR 5.00 0.00 X 0 0 0 GEORGE WALZ DIRECTOR 5.00 0.00 X 0 0 0 HELEN BROOKS DIRECTOR 5.00 0.00 X 0 0 0 IRENE SUDAC DIRECTOR (AS OF 10/2020) 5.00 0.00 X 0 0 0 JAMES GROSSMANN DIRECTOR 5.00 0.00 X 0 0 0 JAY REINSTEIN DIRECTOR 5.00 0.00 X 0 0 0 JOE ARCINIEGA DIRECTOR (AS OF 10/2020) 5.00 0.00 X 0 0 0 KAREN STEVENSON DIRECTOR 5.00 0.00 X 0 0 0 KARYNE JONES DIRECTOR 5.00 0.00 X 0 0 0 MINOO JAVANMARDIAN DIRECTOR 5.00 0.00 X 0 0 0 NICOLE WALKER DIRECTOR (AS OF 10/2020) 5.00 0.00 X 0 0 0 SARAH LORANCE DIRECTOR 5.00 0.00 X 0 0 0 STEVEN OSGOOD DIRECTOR (THRU 10/2020) 5.00 0.50 X 0 0 0 THOMAS DOYLE DIRECTOR (THRU 10/2020) 5.00 0.00 X 0 0 0 WILLIAM THOMAS DIRECTOR 5.00 0.00 X 0 0 0 5381337 12745 886267 272 0 1 0 NAVISTAR DIRECT MARKETING LLC 4612 NAVISTAR DRIVE FREDERICK MD 21703 DIRECT MARKETING 11083133 HAWORTH MARKETING & MEDIA LLC 45 S 7TH STREET SUITE 2400 MINNEAPOLIS MN 55402 ADVERTISING 4819243 NEVER WITHOUT LLC 580 TANACREST ATLANTA GA 30328 ADVERTISING 4346714 WORLD-WIDE PRINTING & DISTRIBUTION INC 2900 E APACHE TULSA OK 74110 DIRECT MARKETING 3463475 BLACKBAUD INC PO BOX 930256 ATLANTA GA 31193 CRM/TECHNOLOGY 2541619 107 421928 4792083 25776739 346438060 7735241 377428810 SAFE RETURN REG. FEES 611710 2305818 2305818 JOURNAL 511120 368826 368826 PROGRAM CONFERENCES 611710 339829 339829 CAREGIVER TRAINING 611710 165463 165463 REG./EVENT REVENUE 900099 138298 138298 3318234 9841519 9841519 74667 74667 34053684 30264 27757200 0 6296484 30264 6326748 6326748 6622732 4792083 371856 6250876 6250876 14979 11845 3134 3134 115729 52535 63194 63194 MISCELLANEOUS REVENUE 900099 1203096 1203096 AFFILIATE REVENUE 900099 16363 16363 1219459 404526641 3318234 0 23779597 51119407 51119407 1207953 1207953 14127989 14127989 3534567 2109247 863817 561503 137567787 101652633 3788273 32126881 12894154 9358716 414580 3120858 17952972 13176414 689891 4086667 9654918 7117086 321478 2216354 875540 614641 129068 131831 155562 155562 1064463 1064463 1642050 1642050 246298 246298 22014841 16692957 1000968 4320916 31814656 29118043 15846 2680767 29739272 18719251 3717709 7302312 827782 600504 93751 133527 21439604 15276641 2988600 3174363 508861 353942 21333 133586 1863518 969261 90654 803603 4332972 2680140 720100 932732 694096 492026 99962 102108 272114 189910 17638 64566 365551376 286641224 15375528 63534624 X 17095210 9059133 2750550 5285527 34909439 25880339 43782942 70423217 8649680 7915070 1143753 1515699 5124112 6281152 44660282 23553028 22615940 21107254 259215453 324420496 34077770 39279061 827593 821608 410346682 497643896 31377893 33248833 82909174 93002734 5775797 3481887 14008354 12813663 134071218 142547117 X 139186350 211697101 137089114 143399678 276275464 355096779 410346682 497643896 X 38975265 36941961 -6200 2910289 X 0 1 X 1 1 1 X 301450526 319867489 361019360 377982664 377428810 1737748849 301450526 319867489 361019360 377982664 377428810 1737748849 1737748849 4882618 6355626 8237819 8384406 9916186 37776655 12716507 12152019 8245835 5689260 7972899 46776520 1822302024 40412265 0.95360 0.95200 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: AFFILIATE REVENUE - 2016 AMOUNT: $ 20,635. 2017 AMOUNT: $ 18,407. 2018 AMOUNT: $ 15,030. 2019 AMOUNT: $ 14,103. 2020 AMOUNT: $ 16,363. FUNDRAISING AND GAMING EVENTS - 2016 AMOUNT: $ 10,444,155. 2017 AMOUNT: $ 10,443,879. 2018 AMOUNT: $ 7,532,657. 2019 AMOUNT: $ 4,700,628. 2020 AMOUNT: $ 6,637,711. INCOME FROM SALES OF INVENTORY - 2016 AMOUNT: $ 38,072. 2017 AMOUNT: $ 318,798. 2018 AMOUNT: $ 242,384. 2019 AMOUNT: $ 132,390. 2020 AMOUNT: $ 115,729. GROUP CHAPTER REVENUE - 2016 AMOUNT: $ 352,995. 2017 AMOUNT: $ 520,936. 2018 AMOUNT: $ 247,444. 2019 AMOUNT: $ 0. 2020 AMOUNT: $ 0. LEGAL SETTLEMENT - 2016 AMOUNT: $ 1,860,650. 2017 AMOUNT: $ 734,166. 2018 AMOUNT: $ 0. 2019 AMOUNT: $ 0. 2020 AMOUNT: $ 0. CHAPTER RENT ABATEMENT - 2016 AMOUNT: $ 0. 2017 AMOUNT: $ 0. 2018 AMOUNT: $ 171,073. 2019 AMOUNT: $ 0. 2020 AMOUNT: $ 0. OTHER INCOME - 2016 AMOUNT: $ 0. 2017 AMOUNT: $ 115,833. 2018 AMOUNT: $ 37,247. 2019 AMOUNT: $ 842,139. 2020 AMOUNT: $ 1,203,096. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1 1 1 300472 0 1 1 6649099 1 1770303 1 129277 0 8849151 0 LINE 1A: VOLUNTEERS MOST OF THE ASSOCIATION'S ADVOCACY IS THROUGH VOLUNTEERS. ADDITIONALLY, THE ASSOCIATION HAS TRAINING TO DEVELOP AND ORGANIZE CHAPTER BASED GRASSROOTS ACTIVITIES. AS ALZHEIMER'S DISEASE AND RELATED DEMENTIAS THREATEN TO BANKRUPT FAMILIES, BUSINESSES AND THE HEALTHCARE SYSTEM, SCIENTISTS ARE MOVING CLOSER TO FINDING BETTER TREATMENTS THAT COULD ALTER THE COURSE OF THE DISEASE. THE ALZHEIMER'S ASSOCIATION ADVOCATES FOR PUBLIC POLICIES AIMED AT ADVANCING RESEARCH TOWARD BETTER THERAPIES, DETECTION, METHODS OF PREVENTION AND ULTIMATELY A CURE, AS WELL AS FOR HIGH QUALITY HEALTHCARE AND LONG-TERM SERVICES AND SUPPORT FOR PEOPLE WITH ALZHEIMER'S AND THEIR FAMILIES. THIS INCLUDES ADVOCACY FOR BETTER CARE FOR PEOPLE AND FAMILIES ALREADY FACING ALZHEIMER'S. ADVOCACY ACTIVITIES ALSO INCLUDE COLLABORATING WITH OTHER ORGANIZATIONS TO IMPROVE QUALITY CARE AND RAISE AWARENESS OF KEY ISSUES. LINE 1B: PAID STAFF OR MANAGEMENT THE ASSOCIATION HAS PAID STAFF WHO ENGAGE ON BEHALF OF THE ASSOCIATION IN PUBLIC POLICY WORK, INCLUDING EDUCATING POLICYMAKERS AND SUPPORTING THE ADVOCACY WORK OF VOLUNTEERS. LINE 1C: MEDIA ADVERTISEMENTS MEDIA ADVERTISEMENTS WERE RUN IN WASHINGTON, D.C. FOR KEY ADVOCACY AWARENESS OPPORTUNITIES DURING THE YEAR. LINE 1D: MAILING TO MEMBERS, LEGISLATORS OR THE PUBLIC DUE TO THE ONGOING COVID-19 PANDEMIC, THERE WERE NO MAILINGS TO LEGISLATORS. LINE 1E: PUBLICATIONS, OR PUBLISHED OR BROADCAST STATEMENTS THE ASSOCIATION DISTRIBUTED FEDERAL AND STATE UPDATES VIA EMAIL APPROXIMATELY 80 TIMES DURING THE YEAR. LINE 1F: GRANTS TO OTHER ORGANIZATIONS FOR LOBBYING PURPOSES THE ASSOCIATION MAKES A GRANT TO ALZHEIMER'S IMPACT MOVEMENT (AIM) WHICH IS USED FOR THE LOBBYING PURPOSES DISCUSSED ABOVE AND WHICH IS ALSO SHOWN ON THE FORM 990 OF AIM AS A LOBBYING EXPENSE. AS SUCH, THE AMOUNT OF THE GRANT IS REPORTED TWICE FOR TRANSPARENCY PURPOSES. LINE 1G: DIRECT CONTACT THE ASSOCIATION USES INTERNAL STAFF AND RETAINED LOBBYISTS TO EDUCATE POLICYMAKERS ABOUT THE ASSOCIATION'S POLICY RECOMMENDATIONS. LINE 1H: RALLIES, DEMONSTRATIONS, SEMINARS, ETC. THE AIM ADVOCACY FORUM WAS HELD VIRTUALLY IN THE CURRECT PERIOD/YEAR. 24252597 252950 4771161 4771161 24505547 24252597 1490922 1490922 24252597 24043831 208766 1557825 1557825 24252597 24038631 5200 894633 894633 24043831 13717133 10321498 1125281 1125281 24038631 1.00000 0 0 568500 568500 1311237 188733 1122504 12179637 6877276 5302361 4118168 2708872 1409296 26482740 13778147 12704593 21107254 BENEFICIAL INTEREST 38940540 F ASSETS HELD IN TRUST 338521 F 39279061 DEFERRED RENT 7814025 GIFT ANNUITY OBLIGATIONS 4999638 12813663 X 454323773 36941961 7111727 5930562 49984250 404339523 246298 -59180 187118 404526641 375502458 7117927 3079453 10197380 365305078 246298 246298 365551376 PART V, LINE 4: INTENDED USES OF ENDOWMENT FUNDS A PORTION OF THE NET ASSETS WITH DONOR RESTRICTIONS ARE RESTRICTED AS INVESTMENTS IN PERPETUITY. THE ASSOCIATION'S ENDOWMENT ONLY CONSISTS OF DONOR-RESTRICTED ENDOWMENT FUNDS. NET ASSETS ASSOCIATED WITH THE ASSOCIATION'S ENDOWMENT FUNDS ARE CLASSIFIED AND REPORTED BASED ON THE EXISTENCE OF DONOR-IMPOSED RESTRICTIONS. DONORS RESTRICT THE EARNINGS OF SOME OF THE ASSOCIATION'S ENDOWMENT FUNDS TO FUND THE ASSOCIATION'S RESEARCH PROGRAM. IN ACCORDANCE WITH DONOR STIPULATIONS, THE INCOME GENERATED FROM THESE ASSETS IS RESTRICTED FOR RESEARCH (APPROXIMATELY 56%) OR NOT PURPOSE RESTRICTED (APPROXIMATELY 44%). THE ASSOCIATION ACCOUNTS FOR ENDOWMENT NET ASSETS BY PRESERVING THE FAIR VALUE OF THE ORIGINAL GIFT AS OF THE GIFT DATE OF THE DONOR-RESTRICTED ENDOWMENT FUND ABSENT EXPLICIT DONOR STIPULATIONS TO THE CONTRARY. AS A RESULT, THE ASSOCIATION CLASSIFIES AS PERMANENTLY RESTRICTED NET ASSETS (1) THE ORIGINAL VALUE OF GIFTS DONATED TO THE PERMANENT ENDOWMENT, (2) THE ORIGINAL VALUE OF SUBSEQUENT GIFTS TO THE PERMANENT ENDOWMENT AND (3) ACCUMULATIONS TO THE PERMANENT ENDOWMENT MADE IN ACCORDANCE WITH THE DIRECTION OF THE APPLICABLE DONOR GIFT INSTRUMENT AT THE TIME THE ACCUMULATION IS ADDED TO THE ENDOWMENT FUND. THE ASSOCIATION CONSIDERS THE FOLLOWING FACTORS IN MAKING A DETERMINATION TO APPROPRIATE OR ACCUMULATE DONOR-RESTRICTED ENDOWMENT FUNDS: - THE DURATION AND PRESERVATION OF THE FUND; - THE PURPOSES OF THE ASSOCIATION AND THE DONOR-RESTRICTED ENDOWMENT FUND; - GENERAL ECONOMIC CONDITIONS; - THE POSSIBLE EFFECTS OF INFLATION AND DEFLATION; - THE EXPECTED TOTAL RETURN FROM INCOME AND THE APPRECIATION OF INVESTMENTS; - OTHER RESOURCES OF THE ASSOCIATION; AND - THE INVESTMENT POLICIES OF THE ASSOCIATION. THE ASSOCIATION HAS ADOPTED AN INVESTMENT POLICY THAT ATTEMPTS TO PROVIDE A PREDICTABLE STREAM OF FUNDING TO PROGRAMS SUPPORTED BY ITS ENDOWMENT WHILE SEEKING TO MAINTAIN THE PURCHASING POWER OF THE ENDOWMENT ASSETS. AS OF JUNE 30, 2021 AND 2020, ENDOWMENT ASSETS ONLY INCLUDE THOSE ASSETS OF DONOR-RESTRICTED FUNDS THAT THE ASSOCIATION MUST HOLD IN PERPETUITY, AS THE ASSOCIATION DOES NOT HAVE ANY BOARD-DESIGNATED ENDOWMENT FUNDS. UNDER THIS POLICY, AS APPROVED BY THE BOARD OF DIRECTORS, THE ENDOWMENT ASSETS ARE INVESTED IN A MANNER THAT IS INTENDED TO PROVIDE ADEQUATE LIQUIDITY, MAXIMIZING RETURNS ON ALL FUNDS INVESTED AND ACHIEVING FULL EMPLOYMENT OF ALL AVAILABLE FUNDS AS EARNING ASSETS. THE ASSOCIATION HAS AN ACTIVE FINANCE COMMITTEE AND INVESTMENT SUB-COMMITTEE THAT MEETS REGULARLY TO ENSURE THAT THE OBJECTIVES OF THE INVESTMENT POLICY ARE MET, AND THAT THE STRATEGIES USED TO MEET THE OBJECTIVES ARE IN ACCORDANCE WITH THE INVESTMENT POLICY. THE ASSOCIATION'S POLICY IS TO APPROPRIATE SPENDING AMOUNTS DEEMED PRUDENT FOR DONOR-RESTRICTED FUNDS. PART X, LINE 2: FIN 48 THE ASSOCIATION AND ALZHEIMER'S IMPACT MOVEMENT (AIM) HAVE RECEIVED FAVORABLE DETERMINATION LETTERS FROM THE INTERNAL REVENUE SERVICE, STATING THAT THEY ARE EXEMPT FROM FEDERAL INCOME TAXES UNDER THE PROVISIONS OF SECTION 501(A) OF THE INTERNAL REVENUE CODE OF 1986 (IRC), AS ORGANIZATIONS DESCRIBED IN SECTIONS 501(C)(3) AND 501(C)(4), RESPECTIVELY, EXCEPT FOR INCOME TAXES PERTAINING TO UNRELATED BUSINESS INCOME. ALZHEIMER'S IMPACT MOVEMENT POLITICAL ACTION COMMITTEE (AIMPAC) IS A POLITICAL ACTION COMMITTEE ORGANIZATION EXEMPT FROM FEDERAL TAXES UNDER SECTION 527 OF THE IRC. THE ALZHEIMER'S ASSOCIATION INTERNATIONAL IS A NOT-FOR-PROFIT CANADIAN ENTITY. THE COALITION OF NEW YORK STATE ALZHEIMER'S ASSOCIATION CHAPTERS, INC. IS A NOT-FOR-PROFIT ORGANIZATION EXEMPT FROM FEDERAL INCOME TAX UNDER SECTION 501(C)(3) OF THE IRC AND HAS NOT BEEN CLASSIFIED AS A PRIVATE FOUNDATION; THEREFORE, NO PROVISION FOR INCOME TAX HAS BEEN MADE IN THE FINANCIAL STATEMENTS. THE FINANCIAL ACCOUNTING STANDARDS BOARD (FASB) ISSUED GUIDANCE THAT REQUIRES TAX EFFECTS FROM UNCERTAIN TAX POSITIONS TO BE RECOGNIZED IN THE CONSOLIDATED FINANCIAL STATEMENTS ONLY IF THE POSITION IS MORE LIKELY THAN NOT TO BE SUSTAINED IF THE POSITION WERE TO BE CHALLENGED BY A TAXING AUTHORITY. MANAGEMENT HAS DETERMINED THERE ARE NO MATERIAL UNCERTAIN POSITIONS THAT REQUIRE RECOGNITION IN THE CONSOLIDATED FINANCIAL STATEMENTS AND, AS SUCH, NO PROVISION FOR INCOME TAXES IS REFLECTED. ADDITIONALLY, THERE ARE NO INTEREST OR PENALTIES RECOGNIZED IN THE CONSOLIDATED STATEMENT OF ACTIVITIES OR STATEMENT OF FINANCIAL POSITION. PART XI, LINE 2D - OTHER ADJUSTMENTS: CHANGE IN PERPETUAL TRUSTS 5,453,372. CHANGE IN SPLIT INTEREST 453,005. REIMBURSEMENT OF RENTAL EXPENSES 24,185. PART XI, LINE 4B - OTHER ADJUSTMENTS: COST OF GOODS SOLD -52,535. GAMING EXPENSES REPORTED ON FORM 990, PART VIII -6,645. PART XII, LINE 2D - OTHER ADJUSTMENTS: BAD DEBT 3,020,273. COST OF GOODS SOLD 52,535. GAMING EXPENSES REPORTED ON FORM 990, PART VIII 6,645. 1 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 GRANTMAKING 8280331 EAST ASIA AND THE PACIFIC 0 0 GRANTMAKING 1953676 SOUTH AMERICA 0 0 GRANTMAKING 1543012 NORTH AMERICA 0 0 GRANTMAKING 1065423 MIDDLE EAST AND NORTH AFRICA 0 0 GRANTMAKING 997165 CENTRAL AMERICA AND THE CARIBBEAN 0 0 GRANTMAKING 238410 SUB-SAHARAN AFRICA 0 0 GRANTMAKING 49972 0 0 0 0 0 0 14127989 0 14127989 EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 199996 WIRE CENTRAL AMERICA AND THE CARIBBEAN PROGRAM SUPPORT 25000 WIRE EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 120000 WIRE SOUTH AMERICA PROGRAM SUPPORT 67983 WIRE SOUTH AMERICA PROGRAM SUPPORT 74057 WIRE EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 24853 WIRE EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 123875 WIRE EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 149600 WIRE EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 149600 WIRE SOUTH AMERICA PROGRAM SUPPORT 68414 WIRE EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 49994 WIRE SOUTH AMERICA PROGRAM SUPPORT 65335 WIRE EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 342218 WIRE EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 24551 WIRE EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 47300 WIRE EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 25000 WIRE EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 149825 WIRE SOUTH AMERICA PROGRAM SUPPORT 73007 WIRE SOUTH AMERICA PROGRAM SUPPORT 34207 WIRE SOUTH AMERICA PROGRAM SUPPORT 149850 WIRE EAST ASIA AND THE PACIFIC PROGRAM SUPPORT 322527 WIRE EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 50000 WIRE SOUTH AMERICA PROGRAM SUPPORT 97632 WIRE EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 175000 WIRE EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 819000 WIRE EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 51500 WIRE EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 25000 WIRE EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 240000 WIRE EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 24997 WIRE EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 374593 WIRE SOUTH AMERICA PROGRAM SUPPORT 315435 WIRE SOUTH AMERICA PROGRAM SUPPORT 25000 WIRE SOUTH AMERICA PROGRAM SUPPORT 25000 WIRE EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 25000 WIRE EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 174905 WIRE EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 25000 WIRE EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 174991 WIRE EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 100000 WIRE NORTH AMERICA PROGRAM SUPPORT 298980 WIRE EAST ASIA AND THE PACIFIC PROGRAM SUPPORT 150000 WIRE CENTRAL AMERICA AND THE CARIBBEAN PROGRAM SUPPORT 150000 WIRE SOUTH AMERICA PROGRAM SUPPORT 102148 WIRE EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 24900 WIRE SOUTH AMERICA PROGRAM SUPPORT 25000 WIRE MIDDLE EAST AND NORTH AFRICA PROGRAM SUPPORT 175000 WIRE EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 33359 WIRE NORTH AMERICA PROGRAM SUPPORT 189940 WIRE SUB-SAHARAN AFRICA PROGRAM SUPPORT 25000 WIRE EAST ASIA AND THE PACIFIC PROGRAM SUPPORT 1040638 WIRE EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 288772 WIRE MIDDLE EAST AND NORTH AFRICA PROGRAM SUPPORT 524661 WIRE NORTH AMERICA PROGRAM SUPPORT 147855 WIRE EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 342348 WIRE EAST ASIA AND THE PACIFIC PROGRAM SUPPORT 119896 WIRE EAST ASIA AND THE PACIFIC PROGRAM SUPPORT 295666 WIRE EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 545570 WIRE SOUTH AMERICA PROGRAM SUPPORT 25000 WIRE SOUTH AMERICA PROGRAM SUPPORT 67143 WIRE SOUTH AMERICA PROGRAM SUPPORT 71068 WIRE CENTRAL AMERICA AND THE CARIBBEAN PROGRAM SUPPORT 63410 WIRE NORTH AMERICA PROGRAM SUPPORT 76744 WIRE SOUTH AMERICA PROGRAM SUPPORT 175000 WIRE EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 768851 WIRE EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 197440 WIRE SOUTH AMERICA PROGRAM SUPPORT 81733 WIRE NORTH AMERICA PROGRAM SUPPORT 275000 WIRE EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 117200 WIRE EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 962000 WIRE EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 623347 WIRE MIDDLE EAST AND NORTH AFRICA PROGRAM SUPPORT 147504 WIRE SUB-SAHARAN AFRICA PROGRAM SUPPORT 24972 WIRE EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 137461 WIRE NORTH AMERICA PROGRAM SUPPORT 76904 WIRE EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 148886 WIRE EAST ASIA AND THE PACIFIC PROGRAM SUPPORT 24949 WIRE EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 49999 WIRE EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 348400 WIRE EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 25000 WIRE MIDDLE EAST AND NORTH AFRICA PROGRAM SUPPORT 150000 WIRE 79 0 0 1 0 0 0 PART I, LINE 2: PROCEDURE FOR MONITORING USE OF GRANT FUNDS OUTSIDE THE UNITED STATES THE OVER-SIGHT OF THE SCIENTIFIC INTEGRITY OF THE ALZHEIMER'S ASSOCIATION INTERNATIONAL RESEARCH GRANT PROGRAM IS THREE-FOLD. FIRST, THE ALZHEIMER'S ASSOCIATION MEDICAL & SCIENTIFIC RELATIONS DIVISION ENSURES PEER-REVIEW AND HIGH QUALITY OF FUNDED AWARDS DURING THE GRANT REVIEW PROCESS, IN CONSULTATION WITH THE VOLUNTARY MEDICAL & SCIENTIFIC ADVISORY GROUP (MSAG) AND THE ALZHEIMER'S ASSOCIATION INTERNATIONAL RESEARCH GRANT PROGRAM (IRGP) COUNCIL. THE ASSOCIATION, WITH INPUT FROM THE IRGP COUNCIL, DEVELOPS FOCUSED REQUESTS FOR APPLICATIONS (RFAS) BASED ON IDENTIFIED NEEDS IN THE ALZHEIMER'S AND ALL DEMENTIA RESEARCH COMMUNITY. SECOND, THE ALZHEIMER'S ASSOCIATION IS ENGAGED IN A CONTINUOUS PORTFOLIO REVIEW OF SCIENTIFIC AREAS OF INVESTMENT TO MONITOR THE DIVERSITY OF THE GRANTS PORTFOLIO, POTENTIAL GAPS IN RESEARCH FUNDING, AND POTENTIAL OVERLAP OF AREAS FUNDED. THE REVIEW INFORMS FUTURE FUNDING OPPORTUNITIES, STRATEGIC ACTIVITIES, AND AREAS OF FUTURE-RFA FOCUS. THIRD, THERE IS A DETAILED PROCESS ONCE A GRANT IS AWARDED TO MONITOR PROGRAM, SCIENTIFIC AND FINANCIAL INTEGRITY. THE ALZHEIMER'S ASSOCIATION MONITORS THE USE OF GRANT FUNDS BOTH INSIDE AND OUTSIDE OF THE UNITED STATES AS FOLLOWS: ALL AWARDEES ARE REQUIRED TO PROVIDE ANNUAL AND, IN SOME CASES, BI-ANNUAL OR QUARTERLY REPORTING TO THE ALZHEIMER'S ASSOCIATION ON BOTH THE STATUS OF THE RESEARCH PROJECT AND FINANCIAL EXPENDITURES ASSOCIATED WITH THE PROJECT. SEVERAL PROGRAMS ARE LEVERAGED FUNDING OPPORTUNITIES WITH PARTNER ORGANIZATIONS. THESE RESEARCH PROJECTS AND FINANCIAL EXPENDITURE REPORTS ARE SHARED BETWEEN THE PARTNER ORGANIZATION(S). SIXTY DAYS PRIOR TO THE ANNIVERSARY OF THE AWARD START DATE, PROPOSALCENTRAL, THE ALZHEIMER'S ASSOCIATION GRANT SYSTEM, SENDS A NOTIFICATION TO RESEARCHERS AND ALL DESIGNATED INSTITUTIONAL FINANCIAL OFFICIALS WITH FISCAL RESPONSIBILITY FOR THE AWARD OF THE REQUIRED REPORTS. THE REQUIRED REPORTING DOCUMENTS INCLUDE AN INTERIM (OR FINAL) SCIENTIFIC REPORT, INTERIM (OR FINAL) FINANCIAL REPORT AND ANY APPLICABLE VARIANCE, MENTOR EVALUATION (IF APPLICABLE), DOCUMENTATION OF ANY PUBLICATIONS AS A RESULT OF ASSOCIATION FUNDING, AND APPLICABLE ANNUAL VERIFICATION OF REQUIRED ETHICAL (ANIMAL AND HUMAN) APPROVALS. THE INSTITUTIONAL OFFICIAL WHO HAS FISCAL RESPONSIBILITY FOR THE AWARD CANNOT BE THE PRIMARY INVESTIGATOR OF THE PROJECT. THE ALZHEIMER'S ASSOCIATION PROVIDES A TEMPLATE FOR THE INTERIM SCIENTIFIC REPORT AND A TEMPLATE FOR THE INTERIM FINANCIAL REPORT, BOTH OF WHICH ARE AVAILABLE FOR DOWNLOAD BY THE RESEARCHERS AS WELL AS THE OFFICIAL WITH FISCAL RESPONSIBILITY FOR THE GRANT AT THE AWARDED INSTITUTION AT HTTPS://PROPOSALCENTRAL.COM. THE FINANCIAL REPORT MUST BE SIGNED BY THE INSTITUTIONAL OFFICIAL WITH FISCAL RESPONSIBILITY, AND ALL REPORTS MUST BE UPLOADED TO PROPOSALCENTRAL. AFTER RECEIPT, ALL FINANCIAL REPORTS ARE REVIEWED BY AN ALZHEIMER'S ASSOCIATION GRANTS STAFF TEAM MEMBER FOR ACCURACY AND CONSISTENCY WITH THE AGREED UPON BUDGET. ANY SIGNIFICANT VARIANCE IN EXPENDITURES TO THE APPROVED BUDGET ALSO REQUIRES A VARIANCE REPORT TO OUTLINE THESE DEVIATIONS IN EXPENSES. IN ADDITION, THE ASSOCIATION REQUIRES PROTOCOL CONTINUATION APPROVAL (I.E., INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE (IACUC), INSTITUTIONAL ETHICAL REVIEW BOARD (IRB, RECOMBINANT RDNA PROTOCOL (RRDNA)) ANNUALLY, IF APPLICABLE FOR THE RESEARCH PROJECT. ANY SUBSEQUENT PAYMENTS TO GRANT AWARDEES ARE GENERATED AFTER THE RECEIPT OF THESE DOCUMENTS AND ULTIMATELY APPROVAL BY THE CHIEF SCIENCE OFFICER, MEDICAL AND SCIENTIFIC RELATIONS TO FORWARD TO FINANCE FOR REVIEW AND PAYMENT. AT THE CONCLUSION OF THE AWARD, ALL REPORTS/PUBLICATION(S) ARE DUE 90 DAYS AFTER THE AWARD EXPIRES AND MUST BE UPLOADED TO THE PROPOSALCENTRAL ONLINE SYSTEM. THE FINANCIAL REPORT MUST BE SIGNED BY THE INSTITUTIONAL OFFICIAL WHO HAS FISCAL RESPONSIBILITY FOR THE AWARD. PUBLICATION(S) AS ACCEPTED ARE UPLOADED TO PROPOSALCENTRAL DURING AND AFTER THE DURATION OF THE GRANT. IT IS EXPECTED THAT AWARDEES WILL CONTINUE TO MAINTAIN RECORD OF ANY PUBLICATION(S) ACKNOWLEDGING THE ALZHEIMER'S ASSOCIATION. DATA GENERATED AS A RESULT OF ALZHEIMER'S ASSOCIATION FUNDED WORK IS SUBJECT TO DATA SHARING, AS A CONDITION OF AWARD. DATA AND OTHER OUTPUTS OF THE PROJECT ARE SUBJECTED TO THIS POLICY FOR QUICK, REASONABLE SUBMISSIONS FOR COMPLETED WORK. FURTHER, AWARDEES AGREE TO SUBMIT/SHARE DATA, AS APPLICABLE, THROUGH THE GLOBAL ALZHEIMER'S ASSOCIATION INTERACTIVE NETWORK (GAAIN*), A GLOBAL INFRASTRUCTURE CONNECTING RESEARCH STUDIES FROM AROUND THE WORLD THROUGH ONE PORTAL WHERE DATA CAN BE INTERROGATED IN AGGREGATE FOR ANALYSIS USING A VIRTUAL MACHINE. GAAIN IS WHOLLY FUNDED BY THE ALZHEIMER'S ASSOCIATION. IN ADDITION, THE ASSOCIATION REQUESTS, MONITORS, AND FOLLOWS-UP TO ENSURE SUBMISSION COMPLIANCE ON ALL AWARDED GRANTS AND THAT FINANCIAL REPORTING REQUIREMENTS ARE MET. AWARDEES' FINANCIAL REPORTS ARE REVIEWED ANNUALLY OR BASED ON THEIR SCHEDULED REPORTING REQUIREMENTS TO ENSURE ELIGIBILITY FOR CONTINUED FUNDING. DELINQUENT REPORT(S) MAY RESULT IN THE WITHDRAWAL OF FUNDING. RESEARCHERS ARE INFORMED THAT DELINQUENT REPORTING COULD LEAD TO WITHDRAWAL OF FUNDING WHEN THE REQUEST FOR ANNUAL REPORT(S) IS SENT. IF FUNDING IS WITHDRAWN DUE TO DELINQUENT REPORTS, ANY UNSPENT FUNDS ABOVE USD $75 MUST BE RETURNED TO THE ALZHEIMER'S ASSOCIATION. FOR-PROFIT ORGANIZATIONS ARE NOT ELIGIBLE TO APPLY TO THE ALZHEIMER'S ASSOCIATION'S INTERNATIONAL RESEARCH GRANT PROGRAM, WITH THE EXCEPTION OF THE PART THE CLOUD TRANSLATIONAL (PTC) RESEARCH GRANT PROGRAM, ALZHEIMER'S INNOVATION AWARD (AIA) AND CERTAIN PARTNERSHIP PROGRAMS, INCLUDING BUT NOT LIMITED TO BIOMARKERS ACROSS NEURODEGENERATIVE DISEASES (BAND) AND TAU PIPELINE ENABLING PROGRAM (T-PEP). ELIGIBILITY OF ORGANIZATIONS APPLICABLE FOR A PROGRAM ARE DETAILED IN THE SPECIFIC PROGRAM'S RFA. FOR THE PART THE CLOUD TRANSLATIONAL (PTC) RESEARCH GRANT PROGRAM AND OTHER PROGRAMS WITH FOR-PROFIT AWARDEES, ANY FOR-PROFIT APPLICANT IS REQUIRED TO SUBMIT THE ORGANIZATION'S FINANCIAL STATEMENTS. AS PART OF THE APPLICATION PROCESS, APPLICANTS ARE TO UPLOAD A W-9 OR W-8BEN FORM THAT HAS BEEN DATED AND SIGNED BY AN AUTHORIZED SIGNING OFFICIAL TO CONFIRM THEIR TAX STATUS. THIS FORM VERIFIES THAT AN INSTITUTION OR ORGANIZATION IS DESIGNATED AS A 501(C)(3) OR OTHER NON-PROFIT ENTITY. FOR PROFIT ORGANIZATIONS MUST SUBMIT DOCUMENTATION OF NET ASSETS AND ANNUAL EARNINGS, IN ADDITION TO THE W-9 OR W-8BEN FORM FOR CONSIDERATION. THESE FORMS ARE UPLOADED WITHIN THEIR SUBMITTED APPLICATION TO PROPOSALCENTRAL. AFTER RECEIPT, THESE FORMS ARE REVIEWED BY AN ALZHEIMER'S ASSOCIATION GRANTS STAFF TEAM MEMBER. FOLLOWING REVIEW, APPLICATIONS ARE THEN MOVED FORWARD TO PEER-REVIEW. IF AWARDED, THE ALZHEIMER'S ASSOCIATION GRANTS STAFF TEAM MEMBER INCLUDES THE APPROPRIATE FORMS IN PAYMENT REQUESTS FOR GRANT FUNDING PAYMENTS. IN ADDITION, FOREIGN INSTITUTIONS ARE REQUIRED TO SUBMIT ONE OF THE FOLLOWING AS VERIFICATION OF NON-PROFIT STATUS: - W-8BEN- ORGANIZATION'S CHARTER, BYLAWS AND OTHER GOVERNING DOCUMENTS (IN ENGLISH, IF POSSIBLE). IN CASES WHERE TRANSLATION IS NOT POSSIBLE, A DATED AND SIGNED LETTER IN ENGLISH FROM THE RECTOR OR OTHER AUTHORIZED SIGNING OFFICIAL OF THE INSTITUTION IS ACCEPTABLE. - DOCUMENTATION OF NON-PROFIT DESIGNATION FROM ORGANIZATION'S GOVERNMENT. PRIOR TO AWARD CONFIRMATION, THE MEDICAL AND SCIENTIFIC RELATIONS DIVISION VERIFIES THAT EACH INSTITUTION IS COMPLIANT WITH THE U.S. PATRIOT ACT AND DOES NOT APPEAR ON THE SPECIALLY DESIGNATED NATIONALS (SDN) LIST. PRIOR TO PAYMENT, EACH FUNDED ALZHEIMER'S ASSOCIATION GRANT AWARDEE (I.E. THE INSTITUTION) IS VERIFIED FOR COMPLIANCE WITH THE U.S. PATRIOT ACT. A GRANTS STAFF TEAM MEMBER CONFIRMS ELIGIBILITY AND PROVIDES THIS DOCUMENTATION TO THE GRANT ONLINE FILE AT PROPOSALCENTRAL PRIOR TO PAYMENT BEING SENT TO THE AWARDEE. IN THE EVENT THAT A POSITIVE MATCH TO ONE OF THE SDN LISTS IS FOUND BY THE ASSOCIATION, IT WILL BE IMMEDIATELY REPORTED TO THE ALZHEIMER'S ASSOCIATION LEGAL DEPARTMENT FOR APPROPRIATE HANDLING AND FOLLOW-UP. FOR TRANSACTIONS UNRELATED TO THE INTERNATIONAL RESEARCH GRANT PROGRAM IN THE MEDICAL AND SCIENTIFIC RELATIONS DEPARTMENT, THE SAME FINANCIAL DOCUMENTATION IS REVIEWED. THE ALZHEIMER'S ASSOCIATION MONITORS THE SCIENTIFIC ADVANCES OF THE ASSOCIATION'S GRANT AWARDEES BY MAINTAINING RECORDS OF PUBLICATIONS, PRESENTATIONS, AND INTELLECTUAL PROPERTY THAT RESULT FROM FUNDED STUDIES. THE ASSOCIATION REQUIRES THE GRANT RECIPIENT TO NOTIFY THE ALZHEIMER'S ASSOCIATION ON AN ANNUAL BASIS WITH UPDATES TO THESE RECORDS. FOLLOW-ON FUNDING FROM FEDERAL AGENCIES AND OTHER FUNDING ORGANIZATIONS, AS ABLE, ARE ALSO MONITORED. * THESE ARE NAMES THAT ARE TRADEMARKS TO ALZHEIMER'S ASSOCIATION. PART I, LINE 3: METHOD USED TO ACCOUNT FOR EXPENDITURES AND GRANTS THE ALZHEIMER'S ASSOCIATION ACCOUNTS FOR EXPENDITURES, CASH GRANTS, AND NONCASH ASSISTANCE USING THE ACCRUAL METHOD. PART II, LINE 1: METHOD USED TO ACCOUNT FOR EXPENDITURES AND GRANTS THE ALZHEIMER'S ASSOCIATION ACCOUNTS FOR EXPENDITURES, CASH GRANTS, AND NONCASH ASSISTANCE USING THE ACCRUAL METHOD. PART III ACCOUNTING METHOD: X X X X X X X 1 THD 80 HAYDEN AVENUE SUITE 300 LEXINGTON MA 02421 MAIL 0 43622082 1392680 42229402 CDR 16900 SCIENCE DRIVE SUITE 210 BOWIE MD 20715 EMAIL 0 31090137 249370 30840767 74712219 1642050 73070169 AL AK AZ AR CA CO CT DE FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY DC MASS/NH GALA 1691389 425889 1265500 3200 OKLAHOMA GALA 886809 -12285 899094 47 8836617 4378479 4458138 155565 186793 26298 11414815 4792083 6622732 158765 186793 26298 371856 6250876 PART I, LINE 2B, BOX (III): FUNDRAISING CONSULTANT - CONTROL ARRANGEMENT THE ALZHEIMER'S ASSOCIATION ENGAGES THOMPSON, HABIB & DENISON INC. (THD) FOR PROFESSIONAL FUNDRAISING CONSULTANT SERVICES. A DESCRIPTION OF THE ARRANGEMENT IS LISTED BELOW: DIRECT MARKETING STRATEGY AND PROGRAM DIRECTION; PRODUCTION MANAGEMENT; DATABASE MANAGEMENT; BUDGETING MANAGEMENT; AND REPORT MANAGEMENT. THE ALZHEIMER'S ASSOCIATION ENGAGES CREATIVE DIRECT RESPONSE, INC. (CDR) FOR PROFESSIONAL FUNDRAISING DIGITAL MARKETING CONSULTANT SERVICES. A DESCRIPTION OF THE ARRANGEMENT IS LISTED BELOW: DIGITAL MARKETING STRATEGY AND PROGRAM DIRECTION; E-MAIL PROGRAM MANAGEMENT; PRODUCTION MANAGEMENT; DATABASE MANAGEMENT; AND BUDGETING MANAGEMENT. PART I, LINE 2B, BOX (VI): FUNDRAISING CONSULTANT - FEE ARRANGEMENT THE AGREEMENT BETWEEN THOMPSON, HABIB & DENISON (THD) AND THE ALZHEIMER'S ASSOCIATION IS NOT A PERCENTAGE-BASED AGREEMENT. THD IS PAID A FIXED FEE PER MONTH. THE ALZHEIMER'S ASSOCIATION EXERCISES CONTROL AND APPROVAL OVER THE CONTENT AND FREQUENCY OF ALL SOLICITATIONS. THE AGREEMENT BETWEEN CREATIVE DIRECT RESPONSE, INC. (CDR) AND THE ALZHEIMER'S ASSOCIATION IS NOT A PERCENTAGE-BASED AGREEMENT. CDR IS PAID A FIXED FEE PER MONTH. THE ALZHEIMER'S ASSOCIATION EXERCISES CONTROL AND APPROVAL. PART II: MANY OF THE FUNDRAISING EVENTS HELD DURING FY21 WERE HELD VIRTUALLY WITH LITTLE TO NO DIRECT EXPENSE, DUE TO THE CONTINUING COVID PANDEMIC. 1 ALBANY MEDICAL COLLEGE 47 NEW SCOTLAND AVENUE ALBANY NY 12208 141338310 501(C)(3) 149997 PROGRAM SUPPORT ALZHEIMER'S IMPACT MOVEMENT 225 NORTH MICHIGAN AVE CHICAGO IL 60601 271961435 501(C)(4) 6649099 PUBLIC POLICY AMERICAN COLLEGE OF RADIOLOGY 1891 PRESTON WHITE DRIVE RESTON VA 20191 362216602 501(C)(3) 881275 PROGRAM SUPPORT ARIZONA STATE UNIVERSITY PO BOX 876011 TEMPE AZ 85287 860196696 501(C)(3) 150000 PROGRAM SUPPORT BAYLOR COLLEGE OF MEDICINE ONE BAYLOR PLAZA MS BCM 310 HOUSTON TX 77030 741613878 501(C)(3) 500000 PROGRAM SUPPORT BEDFORD VA RESEARCH CORPORATION INC 200 SPRINGS ROAD BEDFORD MA 01730 043512440 501(C)(3) 44385 PROGRAM SUPPORT BOSTON VA RESEARCH INSTITUTE INC 150 SOUTH HUNTINGTON AVE BOSTON MA 02130 043081524 501(C)(3) 49953 PROGRAM SUPPORT BRIGHAM AND WOMEN'S HOSPITAL INC 75 FRANCIS STREET BOSTON MA 02115 042312909 501(C)(3) 522277 PROGRAM SUPPORT BROAD INSTITUTE INC 415 MAIN STREET CAMBRIDGE MA 02142 263428781 501(C)(3) 3057575 PROGRAM SUPPORT BUCK INSTITUTE FOR RESEARCH ON AGING 8001 REDWOOD BLVD NOVATO CA 94945 943030609 501(C)(3) 150000 PROGRAM SUPPORT BUTLER HOSPITAL 345 BLACKSTONE BOULEVARD PROVIDENCE RI 02906 050258812 501(C)(3) 125000 PROGRAM SUPPORT CASE WESTERN RESERVE UNIVERSITY - SCHOOL OF MEDICINE 10900 EUCLID AVENUE CLEVELAND OH 44106 341018992 501(C)(3) 150000 PROGRAM SUPPORT CEDARS-SINAI MEDICAL CENTER 8700 BEVERLY BOULEVARD SUITE 1150 LOS ANGELES CA 90048 951644600 501(C)(3) 325000 PROGRAM SUPPORT CHILDREN'S HOSPITAL BOSTON 300 LONGWOOD AVENUE BOSTON MA 02115 042774441 501(C)(3) 1001307 PROGRAM SUPPORT CITY OF LAUDERDALE LAKES 4320 NW 36TH ST FORT LAUDERDALE FL 33319 590974050 501(C)(3) 15989 PROGRAM SUPPORT COLORADO STATE UNIVERSITY 2002 CAMPUS DELIVERY FORT COLLINS CO 80523 846000545 501(C)(3) 149983 PROGRAM SUPPORT COLUMBIA UNIVERSITY MEDICAL CENTER 630 WEST 168TH STREET NEW YORK NY 10032 135598093 501(C)(3) 1683475 PROGRAM SUPPORT CREATIVE AGENTS OF CHANGE FOUNDATION INC DBA IDEAS XLAB 633 E MAIN ST UNIT 340 LOUISVILLE KY 40202 463469821 501(C)(3) 25000 PROGRAM SUPPORT EMORY UNIVERSITY 1599 CLIFTON ROAD NE ATLANTA GA 30322 580566256 501(C)(3) 91780 PROGRAM SUPPORT FLORIDA ATLANTIC UNIVERSITY 777 GLADES ROAD BOCA RATON FL 33431 650385507 501(C)(3) 299870 PROGRAM SUPPORT FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH INC 9650 ROCKVILLE PIKE BETHESDA MD 20814 521986675 501(C)(3) 338000 PROGRAM SUPPORT GEORGIA INSTITUTE OF TECHNOLOGY NORTH AVE NW ATLANTA GA 30332 580603146 501(C)(3) 173500 PROGRAM SUPPORT GEORGIA STATE UNIVERSITY 38 PEACHTREE CENTER AVE STE 540 ATLANTA GA 30302 586002050 501(C)(3) 150000 PROGRAM SUPPORT HOWARD UNIVERSITY 525 BRYANT STREET NW SUITE 137 WASHINGTON DC 20059 530204707 501(C)(3) 119974 PROGRAM SUPPORT ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI ONE GUSTAVE L LEVY PLACE NEW YORK NY 10029 136171197 501(C)(3) 585000 PROGRAM SUPPORT ILLINOIS INSTITUTE OF TECHNOLOGY 3255 S DEARBORN ST SUITE 221 CHICAGO IL 60616 362170136 501(C)(3) 49923 PROGRAM SUPPORT INDIANA UNIVERSITY 509 E 3RD STREET BLOOMINGTON IN 47401 356001673 501(C)(3) 521730 PROGRAM SUPPORT MASSACHUSETTS GENERAL HOSPITAL 55 FRUIT STREET BOSTON MA 02114 042697983 501(C)(3) 757770 PROGRAM SUPPORT MAYO CLINIC 200 FIRST ST SW ROCHESTER MN 55905 416011702 501(C)(3) 175000 PROGRAM SUPPORT MAYO CLINIC JACKSONVILLE 4500 SAN PABLO ROAD JACKSONVILLE FL 32224 593337028 501(C)(3) 924473 PROGRAM SUPPORT MEDICAL UNIVERSITY OF SOUTH CAROLINA 179 ASHLEY AVE CHARLESTON SC 29425 576000722 501(C)(3) 174999 PROGRAM SUPPORT MENORAH HOME AND HOSPITAL 1516 ORIENTAL BOULEVARD BROOKLYN NY 11235 111672777 501(C)(3) 50000 PROGRAM SUPPORT NEW YORK UNIVERSITY SCHOOL OF MEDICINE ONE PARK AVENUE 6TH FLOOR NEW YORK NY 10016 135562308 501(C)(3) 2609390 PROGRAM SUPPORT NORTH CAROLINA CENTRAL UNIVERSITY 1801 FAYETTEVILLE STREET DURHAM NC 27707 566000730 501(C)(3) 49501 PROGRAM SUPPORT OREGON HEALTH & SCIENCE UNIVERSITY 3181 SW SAM JACKSON PARK ROAD PORTLAND OR 97239 931176109 501(C)(3) 49999 PROGRAM SUPPORT QINOTTO INC 30 SUMMERHOLME PL HILLSBOROUGH CA 94010 844030745 N/A 1000000 PROGRAM SUPPORT REGENTS OF THE UNIVERSITY OF MINNESOTA - TWIN CITIES 420 DELAWARE STREET SE MINNEAPOLIS MN 55455 416007513 501(C)(3) 210479 PROGRAM SUPPORT RUSH UNIVERSITY MEDICAL CENTER 1653 W CONGRESS PARKWAY CHICAGO IL 60612 362174823 501(C)(3) 637925 PROGRAM SUPPORT RUTGERS THE STATE UNIVERSITY OF NJ 100 STRUBLE ROAD BRANCHVILLE NJ 08854 226001086 501(C)(3) 150000 PROGRAM SUPPORT SOUTH CAROLINA DEPARTMENT OF AGING 1301 GERVAIS ST STE 200 COLUMBIA SC 29201 576000286 501(C)(3) 919013 PROGRAM SUPPORT STANFORD UNIVERSITY 455 BDWY DISCOVERY HALL 2ND FL REDWOOD CITY CA 94063 941156365 501(C)(3) 944725 PROGRAM SUPPORT TEXAS A&M UNIVERSITY HEALTH SCIENCE CENTER 400 HARVEY MITCHELL PARKWAY SOUTH SUITE 300 COLLEGE STATION TX 77845 742907553 501(C)(3) 174828 PROGRAM SUPPORT THE JACKSON LABORATORY 600 MAIN STREET BAR HARBOR ME 04609 010211513 501(C)(3) 923631 PROGRAM SUPPORT THE METHODIST HOSPITAL RESEARCH INSTITUTE 7550 GREENBRIAR DR HOUSTON TX 77030 870721923 501(C)(3) 2387072 PROGRAM SUPPORT THE RECTOR AND VISITORS OF THE UNIVERSITY OF VIRGINIA OFFICE OF SPONSORED PROGRAMS PO BOX 400195 CHARLOTTESVILLE VA 22904 546001796 501(C)(3) 449165 PROGRAM SUPPORT THE REGENTS OF THE UNIVERSITY OF CALIFORNIA DAVIS 1850 RESEARCH PARK DRIVE SUITE 300 DAVIS CA 95618 946036494 501(C)(3) 10000 PROGRAM SUPPORT THE REGENTS OF THE UNIVERSITY OF CALIFORNIA IRVINE 141 INNOVATION SUITE 250 IRVINE CA 92697 952226406 501(C)(3) 512438 PROGRAM SUPPORT THE REGENTS OF THE UNIVERSITY OF CALIFORNIA LOS ANGELES 10889 WILSHIRE BOULEVARD SUITE 700 LOS ANGELES CA 90095 956006143 501(C)(3) 223867 PROGRAM SUPPORT THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN DIEGO 9500 GILMAN DRIVE LA JOLLA CA 92093 956006144 501(C)(3) 180030 PROGRAM SUPPORT THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO 3333 CALIFORNIA STREET SUITE 315 SAN FRANCISCO CA 94118 946036493 501(C)(3) 5305224 PROGRAM SUPPORT THE REGENTS OF THE UNIVERSITY OF MICHIGAN 3003 S STATE STREET ANN ARBOR MI 48109 386006309 501(C)(3) 593895 PROGRAM SUPPORT THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 3451 WALNUT STREET 5TH FLOOR PHILADELPHIA PA 19104 231352685 501(C)(3) 524395 PROGRAM SUPPORT THE UNIVERSITY OF CHICAGO 6054 S DREXEL AVENUE SUITE 300 CHICAGO IL 60637 362177139 501(C)(3) 150000 PROGRAM SUPPORT THE UNIVERSITY OF IOWA 2 GILMORE HALL IOWA CITY IA 52242 426004813 501(C)(3) 300000 PROGRAM SUPPORT THE UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER 62 S DUNLAP SUITE 300 MEMPHIS TN 38163 626001636 501(C)(3) 149991 PROGRAM SUPPORT THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON 7000 FANNIN UCT 1006 HOUSTON TX 77030 741761309 501(C)(3) 374594 PROGRAM SUPPORT THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO 7703 FLOYD CURL DRIVE SAN ANTONIO TX 78229 741586031 501(C)(3) 322065 PROGRAM SUPPORT THE UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON 301 UNIVERSITY BOULEVARD GALVESTON TX 77555 746000949 501(C)(3) 140000 PROGRAM SUPPORT UNIVERSITY OF ALABAMA AT BIRMINGHAM 1720 2ND AVENUE SOUTH BIRMINGHAM AL 35294 636005396 501(C)(3) 324997 PROGRAM SUPPORT UNIVERSITY OF ARIZONA P O BOX 210158 ROOM 510 TUCSON AZ 85719 742652689 501(C)(3) 174843 PROGRAM SUPPORT UNIVERSITY OF CINCINNATI 51 GOODMAN DRIVE CINCINNATI OH 45221 316000989 501(C)(3) 150000 PROGRAM SUPPORT UNIVERSITY OF CONNECTICUT HEALTH CENTER 263 FARMINGTON AVENUE FARMINGTON CT 06030 521725543 501(C)(3) 50000 PROGRAM SUPPORT UNIVERSITY OF FLORIDA 207 GRINTER HALL GAINESVILLE FL 32611 596002052 501(C)(3) 270000 PROGRAM SUPPORT UNIVERSITY OF HOUSTON 4302 UNIVERSITY DRIVE HOUSTON TX 77204 746001399 501(C)(3) 50000 PROGRAM SUPPORT UNIVERSITY OF MARYLAND BALTIMORE 620 W LEXINGTON STREET 4TH FLOOR BALTIMORE MD 21201 526002033 501(C)(3) 149907 PROGRAM SUPPORT UNIVERSITY OF MIAMI 1320 SOUTH DIXIE HIGHWAY STE 650 CORAL GABLES FL 33146 590624458 501(C)(3) 150000 PROGRAM SUPPORT UNIVERSITY OF MISSISSIPPI MEDICAL CENTER 2500 NORTH STATE STREET JACKSON MS 39216 646008520 501(C)(3) 150000 PROGRAM SUPPORT UNIVERSITY OF NORTH DAKOTA 264 CENTENNIAL DR GRAND FORKS ND 58202 456002491 501(C)(3) 175000 PROGRAM SUPPORT UNIVERSITY OF ROCHESTER 518 HYLAN BLDG BOX 270140 ROCHESTER NY 14627 160743209 501(C)(3) 175000 PROGRAM SUPPORT UNIVERSITY OF SOUTH FLORIDA 4019 E FOWLER AVE SUITE 100 TAMPA FL 33617 593102112 501(C)(3) 41209 PROGRAM SUPPORT UNIVERSITY OF SOUTHERN CALIFORNIA 3720 S FLOWER STREET 3RD FLOOR LOS ANGELES CA 90089 951642394 501(C)(3) 3298433 PROGRAM SUPPORT UNIVERSITY OF UTAH 75 S 2000 SALT LAKE CITY UT 84112 876000525 501(C)(3) 150000 PROGRAM SUPPORT UNIVERSITY OF WISCONSIN-MADISON 21 NORTH PARK STREET SUITE 6401 MADISON WI 53715 396006492 501(C)(3) 44019 PROGRAM SUPPORT VANDERBILT UNIVERSITY MEDICAL CENTER 3319 WEST END AVE STE 970 NASHVILLE TN 37203 352528741 501(C)(3) 149899 PROGRAM SUPPORT WAKE FOREST UNIVERSITY HEALTH SCIENCES MEDICAL CENTER BLVD WINSTONSALEM NC 27157 223849199 501(C)(3) 4518811 PROGRAM SUPPORT WASHINGTON STATE UNIVERSITY 280 LIGHTY PULLMAN WA 99164 916001108 501(C)(3) 173906 PROGRAM SUPPORT WASHINGTON UNIVERSITY IN STLOUIS ONE BROOKING DRIVE ST LOUIS MO 63130 430653611 501(C)(3) 2703410 PROGRAM SUPPORT WAYNE STATE UNIVERSITY 5057 WOODWARD STE 13202 DETROIT MI 48202 386028429 501(C)(3) 175000 PROGRAM SUPPORT 76 2 PART I, LINE 2: PROCEDURE FOR MONITORING USE OF GRANT FUNDS INSIDE THE UNITED STATES. THE OVER-SIGHT OF THE SCIENTIFIC INTEGRITY OF THE ALZHEIMER'S ASSOCIATION INTERNATIONAL RESEARCH GRANT PROGRAM IS THREE-FOLD. FIRST, THE ALZHEIMER'S ASSOCIATION MEDICAL & SCIENTIFIC RELATIONS DIVISION ENSURES PEER-REVIEW AND HIGH QUALITY OF FUNDED AWARDS DURING THE GRANT REVIEW PROCESS, IN CONSULTATION WITH THE VOLUNTARY MEDICAL & SCIENTIFIC ADVISORY GROUP (MSAG) AND THE ALZHEIMER'S ASSOCIATION INTERNATIONAL RESEARCH GRANT PROGRAM (IRGP) COUNCIL. THE ASSOCIATION, WITH INPUT FROM THE IRGP COUNCIL, DEVELOPS FOCUSED REQUESTS FOR APPLICATIONS (RFAS) BASED ON IDENTIFIED NEEDS IN THE ALZHEIMER'S AND ALL DEMENTIA RESEARCH COMMUNITY. SECOND, THE ALZHEIMER'S ASSOCIATION IS ENGAGED IN A CONTINUOUS PORTFOLIO REVIEW OF SCIENTIFIC AREAS OF INVESTMENT TO MONITOR THE DIVERSITY OF THE GRANTS PORTFOLIO, POTENTIAL GAPS IN RESEARCH FUNDING, AND POTENTIAL OVERLAP OF AREAS FUNDED. THE REVIEW INFORMS FUTURE FUNDING OPPORTUNITIES, STRATEGIC ACTIVITIES, AND AREAS OF FUTURE-RFA FOCUS. THIRD, THERE IS A DETAILED PROCESS ONCE A GRANT IS AWARDED TO MONITOR PROGRAM, SCIENTIFIC AND FINANCIAL INTEGRITY. THE ALZHEIMER'S ASSOCIATION MONITORS THE USE OF GRANT FUNDS BOTH INSIDE AND OUTSIDE OF THE UNITED STATES AS FOLLOWS: ALL AWARDEES ARE REQUIRED TO PROVIDE ANNUAL AND, IN SOME CASES, BI-ANNUAL OR QUARTERLY REPORTING TO THE ALZHEIMER'S ASSOCIATION ON BOTH THE STATUS OF THE RESEARCH PROJECT AND FINANCIAL EXPENDITURES ASSOCIATED WITH THE AWARD. SEVERAL PROGRAMS ARE LEVERAGED FUNDING OPPORTUNITIES WITH PARTNER ORGANIZATIONS. THESE RESEARCH PROJECTS AND FINANCIAL EXPENDITURE REPORTS ARE SHARED BETWEEN THE PARTNER ORGANIZATION(S). SIXTY DAYS PRIOR TO THE ANNIVERSARY OF THE AWARD START DATE, AN ALZHEIMER'S ASSOCIATION GRANTS STAFF TEAM MEMBER NOTIFIES ALL RESEARCHERS AND ALL DESIGNATED INSTITUTIONAL FINANCIAL OFFICIALS WITH FISCAL RESPONSIBILITY FOR THE AWARD OF THE REQUIRED REPORTS, WHICH INCLUDE AN INTERIM SCIENTIFIC REPORT, INTERIM FINANCIAL REPORT, DOCUMENTATION OF ANY PUBLICATIONS AS A RESULT OF ASSOCIATION FUNDING, AND ANNUAL VERIFICATION, AS APPLICABLE, OF REQUIRED ETHICAL (ANIMAL AND HUMAN) APPROVALS. THE INSTITUTIONAL OFFICIAL WHO HAS FISCAL RESPONSIBILITY FOR THE AWARD CANNOT BE THE PRIMARY INVESTIGATOR OF THE PROJECT. THE ALZHEIMER'S ASSOCIATION PROVIDES A TEMPLATE FOR THE INTERIM SCIENTIFIC REPORT AND A TEMPLATE FOR THE INTERIM FINANCIAL REPORT, BOTH OF WHICH ARE AVAILABLE FOR DOWNLOAD BY THE RESEARCHERS AS WELL AS THE OFFICIAL WITH FISCAL RESPONSIBILITY FOR THE GRANT AT THE AWARDED INSTITUTION AT HTTPS://PROPOSALCENTRAL.COM/. THE FINANCIAL REPORT MUST BE SIGNED BY THE INSTITUTIONAL OFFICIAL WITH FISCAL RESPONSIBILITY, AND ALL REPORTS MUST BE UPLOADED BY THE AWARD RECIPIENT TO PROPOSALCENTRAL. AFTER RECEIPT, ALL FINANCIAL REPORTS ARE REVIEWED BY AN ALZHEIMER'S ASSOCIATION GRANTS STAFF TEAM MEMBER FOR ACCURACY AND CONSISTENCY WITH THE AGREED UPON BUDGET. ANY SIGNIFICANT VARIANCE IN EXPENDITURES TO THE APPROVED BUDGET ALSO REQUIRES A VARIANCE REPORT TO OUTLINE THESE DEVIATIONS IN EXPENSES. IN ADDITION, THE ASSOCIATION REQUIRES PROTOCOL CONTINUATION APPROVAL (I.E., INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE (IACUC), INSTITUTIONAL REVIEW BOARD (IRB), RECOMBINANT RDNA PROTOCOL (RRDNA) ANNUALLY, IF APPLICABLE FOR THE RESEARCH PROJECT. ANY SUBSEQUENT PAYMENTS TO GRANT AWARDEES ARE GENERATED AFTER THE RECEIPT OF THESE DOCUMENTS AND ULTIMATELY APPROVAL BY THE CHIEF SCIENCE OFFICER, MEDICAL AND SCIENTIFIC RELATIONS TO FORWARD TO FINANCE FOR REVIEW AND PAYMENT. AT THE CONCLUSION OF THE AWARD, ALL REPORTS/PUBLICATION(S) ARE DUE 90 DAYS AFTER THE AWARD EXPIRES AND MUST BE UPLOADED TO THE PROPOSALCENTRAL ONLINE SYSTEM. THE FINANCIAL REPORT MUST BE SIGNED BY THE INSTITUTIONAL OFFICIAL WHO HAS FISCAL RESPONSIBILITY FOR THE AWARD. PUBLICATION(S) AS ACCEPTED ARE UPLOADED TO PROPOSALCENTRAL DURING AND AFTER THE DURATION OF THE GRANT. IT IS EXPECTED THAT AWARDEES WILL CONTINUE TO MAINTAIN RECORDS OF ANY PUBLICATION(S) ACKNOWLEDGING THE ALZHEIMER'S ASSOCIATION. DATA GENERATED AS A RESULT OF ALZHEIMER'S ASSOCIATION FUNDED WORK IS SUBJECT TO DATA SHARING, AS A CONDITION OF AWARD. DATA AND OTHER OUTPUTS OF THE PROJECT ARE SUBJECTED TO THIS POLICY FOR QUICK, REASONABLE SUBMISSIONS FOR COMPLETED WORK. FURTHER, AWARDEES AGREE TO SUBMIT/SHARE DATA, AS APPLICABLE, THROUGH THE GLOBAL ALZHEIMER'S ASSOCIATION INTERACTIVE NETWORK (GAAIN*), A GLOBAL INFRASTRUCTURE CONNECTING RESEARCH STUDIES FROM AROUND THE WORLD THROUGH ONE PORTAL WHERE DATA CAN BE INTERROGATED IN AGGREGATE FOR ANALYSIS USING A VIRTUAL MACHINE. GAAIN IS WHOLLY FUNDED BY THE ALZHEIMER'S ASSOCIATION. IN ADDITION, THE ASSOCIATION REQUESTS, MONITORS, AND FOLLOWS-UP TO ENSURE SUBMISSION COMPLIANCE ON ALL AWARDED GRANTS AND THAT FINANCIAL REPORTING REQUIREMENTS ARE MET. AWARDEES' FINANCIAL REPORTS ARE REVIEWED ANNUALLY OR BASED ON THEIR SCHEDULED REPORTING REQUIREMENTS TO ENSURE ELIGIBILITY FOR CONTINUED FUNDING. DELINQUENT REPORT(S) MAY RESULT IN THE WITHDRAWAL OF FUNDING. RESEARCHERS ARE INFORMED THAT DELINQUENT REPORTING COULD LEAD TO WITHDRAWAL OF FUNDING WHEN THE REQUEST FOR ANNUAL REPORT(S) IS SENT. IF FUNDING IS WITHDRAWN DUE TO DELINQUENT REPORTS, ANY UNSPENT FUNDS ABOVE USD $75 MUST BE RETURNED TO THE ALZHEIMER'S ASSOCIATION. FOR-PROFIT ORGANIZATIONS ARE NOT ELIGIBLE TO APPLY TO THE ALZHEIMER'S ASSOCIATION'S INTERNATIONAL RESEARCH GRANT PROGRAM, WITH THE EXCEPTION OF THE PART THE CLOUD (PTC) TRANSLATIONAL RESEARCH GRANT, ALZHEIMER'S INNOVATION AWARD (AIA) AND CERTAIN PARTNERSHIP PROGRAMS, INCLUDING BUT NOT LIMITED TO BIOMARKERS ACROSS NEURODEGENERATIVE DISEASES (BAND) AND TAU PIPELINE ENABLING PROGRAM (T-PEP). ELIGIBILITY OF ORGANIZATIONS APPLICABLE FOR A PROGRAM ARE DETAILED IN THE SPECIFIC PROGRAM'S RFA. FOR THE PART THE CLOUD TRANSLATIONAL RESEARCH (PTC) GRANT PROGRAM AND OTHER PROGRAMS WITH FOR-PROFIT AWARDEES, ANY FOR-PROFIT APPLICANT IS REQUIRED TO SUBMIT THE ORGANIZATION'S FINANCIAL STATEMENTS IN ADDITION TO THE W-9 OR W-8BEN FORM. AS PART OF THE APPLICATION PROCESS, APPLICANTS ARE REQUIRED TO UPLOAD A W-9 FORM THAT HAS BEEN DATED AND SIGNED BY AN AUTHORIZED SIGNING OFFICIAL. THIS FORM VERIFIES THAT AN INSTITUTION OR ORGANIZATION IS DESIGNATED AS A 501(C)(3) OR OTHER NON-PROFIT ENTITY. FOR PROFIT ORGANIZATIONS MUST SUBMIT DOCUMENTATION OF NET ASSETS AND ANNUAL EARNINGS, IN ADDITION TO THE W-9 OR W-8BEN FORM FOR CONSIDERATION. THESE FORMS ARE UPLOADED WITHIN THEIR SUBMITTED APPLICATION TO PROPOSALCENTRAL. AFTER RECEIPT, THESE FORMS ARE REVIEWED BY AN ALZHEIMER'S ASSOCIATION GRANTS STAFF TEAM MEMBER. FOLLOWING REVIEW BY A GRANTS STAFF TEAM MEMBER, APPLICATIONS ARE THEN MOVED FORWARD TO PEER-REVIEW. IF AWARDED, THE ALZHEIMER'S ASSOCIATION GRANTS STAFF TEAM MEMBER INCLUDES THE APPROPRIATE FORMS IN PAYMENT REQUESTS FOR GRANT FUNDING PAYMENTS. PRIOR TO AWARD CONFIRMATION, THE MEDICAL AND SCIENTIFIC RELATIONS DIVISION VERIFIES THAT EACH INSTITUTION IS COMPLIANT WITH THE U.S. PATRIOT ACT AND DOES NOT APPEAR ON THE SPECIALLY DESIGNATED NATIONALS (SDN) LISTS. PRIOR TO PAYMENT, EACH FUNDED ALZHEIMER'S ASSOCIATION GRANT AWARDEE (I.E. THE INSTITUTION) IS VERIFIED FOR COMPLIANCE WITH THE U.S. PATRIOT ACT. THE GRANTS STAFF TEAM MEMBER CONFIRMS ELIGIBILITY AND PROVIDES THIS DOCUMENTATION TO THE GRANT ONLINE FILE AT PROPOSALCENTRAL PRIOR TO PAYMENT BEING SENT TO THE AWARDEE. IN THE EVENT THAT A POSITIVE MATCH TO ONE OF THE SDN LISTS IS FOUND BY THE ASSOCIATION, IT WOULD IMMEDIATELY BE REPORTED TO THE ALZHEIMER'S ASSOCIATION LEGAL DEPARTMENT FOR APPROPRIATE HANDLING AND FOLLOW-UP. FOR TRANSACTIONS UNRELATED TO THE INTERNATIONAL RESEARCH GRANT PROGRAM IN THE MEDICAL AND SCIENTIFIC DEPARTMENT, THE SAME FINANCIAL DOCUMENTATION IS REVIEWED. THE ALZHEIMER'S ASSOCIATION MONITORS THE SCIENTIFIC ADVANCES OF THE ASSOCIATION'S GRANT AWARDEES BY MAINTAINING RECORDS OF PUBLICATIONS, PRESENTATIONS, AND INTELLECTUAL PROPERTY THAT RESULT FROM FUNDED STUDIES. THE ASSOCIATION REQUIRES THE GRANT RECIPIENT TO NOTIFY THE ALZHEIMER'S ASSOCIATION ON AN ANNUAL BASIS WITH UPDATES TO THESE RECORDS. FOLLOW-ON FUNDING FROM FEDERAL AGENCIES IS ALSO MONITORED. THE ALZHEIMER'S ASSOCIATION GRANTED FUNDS TO ALZHEIMER'S IMPACT MOVEMENT (AIM) FOR PUBLIC POLICY DIVISION ACTIVITIES IN FISCAL YEAR 2021 TO SUPPORT PRIORITIES IDENTIFIED IN THE ALZHEIMER'S ASSOCIATION'S STRATEGIC PLAN. THIS GRANT IS RESTRICTED TO THE FOLLOWING 501(C)(3) ACTIVITIES AND THE ANCILLARY ACTIVITIES NECESSARY TO ACCOMPLISH SPECIFIC GOALS INCLUDING: IMPLEMENTATION OF THE NATIONAL ALZHEIMER'S PROJECT ACT (RECOGNIZING THIS GROWING ALZHEIMER'S CRISIS, CONGRESS UNANIMOUSLY PASSED AND THE PRESIDENT SIGNED INTO LAW THE NATIONAL ALZHEIMER'S PROJECT ACT -NAPA); INCREASING THE COMMITMENT TO ALZHEIMER'S RESEARCH; EXPANDING EDUCATION EFFORTS AND CAREGIVER SUPPORT SERVICES; EXPANDING DIAGNOSIS AND PLANNING. * THESE ARE NAMES THAT ARE TRADEMARKS TO ALZHEIMER'S ASSOCIATION. X 1 1 X X X X X 0 0 0 0 0 0 0 0 0 HARRY JOHNS PRESIDENT & CEO 410098 3144 394000 0 1518 0 184459 0 26787 0 1016862 3144 0 0 DONNA MCCULLOUGH CHIEF FIELD & DEVELOP. OFFICER 456921 0 142500 0 101613 0 45921 0 12773 0 759728 0 100000 0 KATHERINE JOANNE PIKE CHIEF STRATEGY OFFICER 469291 223 150000 0 1511 0 59755 0 34389 0 714946 223 0 0 RICHARD HOVLAND COO & ASST. TREAS. 455632 902 141120 0 3652 0 62228 0 29862 0 692494 902 0 0 MARIA CARRILLO CHIEF SCIENCE OFFICER 416519 0 126315 0 823 0 58814 0 35804 0 638275 0 0 0 ROBERT EGGE CHIEF PUBLIC POLICY OFFICER 398447 8171 126315 0 809 0 54726 0 35198 0 615495 8171 0 0 GLENDA BERRY WEST AREA LEADER 357490 0 111150 0 2307 0 51712 0 24654 0 547313 0 0 0 KENANN CASSIDY EAST AREA LEADER 359708 0 111150 0 3464 0 51712 0 16269 0 542303 0 0 0 MICHELLE HELTON CHIEF FINANCIAL OFFICER 292982 0 69460 0 1694 0 27364 0 37383 0 428883 0 0 0 CHRISTINE FOH ASST. SECY. & VP LEGAL & GC 236999 305 35816 0 2033 0 26855 0 9602 0 311305 305 0 0 PART I, LINE 1A TRAVEL FOR COMPANIONS AT TIMES A BOARD MEMBER WITH EARLY ONSET ALZHEIMER'S DISEASE MAY REQUIRE A COMPANION TO ACCOMPANY HIM OR HER ON BUSINESS TRAVEL FOR SAFETY REASONS. SINCE HIS OR HER INVOLVEMENT IN THE MEETINGS IS CRITICAL TO REPRESENTING KEY CONSTITUENTS AND APPROPRIATELY FULFILLING THE MISSION OF THE ALZHEIMER'S ASSOCIATION, THE EXPENSES OF COMPANION TRAVEL ARE REIMBURSED. PART I, LINE 4 SUPPLEMENTAL NON-QUALIFIED RETIREMENT PLAN THERE WERE NO ADDITIONAL AMOUNTS ACCRUED OR REPORTED FOR HARRY JOHNS OR RICHARD HOVLAND RELATED TO A 457(B) PLAN IN CALENDAR YEAR 2020. PART II, COLUMN (B) (I): CEO SALARY REDUCTION THE BASE COMPENSATION REPORTED FOR MR. JOHNS (PRESIDENT AND CEO) REFLECTS A ONE-TIME SUBSTANTIAL REDUCTION REQUESTED BY MR. JOHNS, AND APPROVED BY THE BOARD, DURING THE FIRST SEVERAL MONTHS OF THE COVID-19 CRISIS IN 2020. WHEN MR. JOHNS' REGULAR RATE OF BASE COMPENSATION WAS RESTORED SEVERAL MONTHS LATER, THE VOLUNTARY SALARY REDUCTION AMOUNT WAS NOT REPAID. PART II, COLUMN (B) (II): SUPPLEMENTAL COMPENSATION INFORMATION: BONUS AND INCENTIVE COMPENSATION HARRY JOHNS RECEIVED PERFORMANCE BASED INCENTIVE COMPENSATION OF $394,000 BASED ON HIS SUCCESSFUL ACHIEVEMENT OF SPECIFIC GOALS, WHICH WERE DEVELOPED, REVIEWED, AND APPROVED BY THE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS IN CONSULTATION WITH THE BOARD'S INDEPENDENT THIRD-PARTY COMPENSATION CONSULTANTS. THIS PERFORMANCE BASED INCENTIVE COMPENSATION WAS EARNED FOR PERFORMANCE IN FISCAL YEAR 2020 AND WAS PAID IN CALENDAR YEAR 2020. RICHARD HOVLAND, JOANNE PIKE, DONNA MCCULLOUGH, ROBERT EGGE, MARIA CARRILLO, GLENDA BERRY, KENANN CASSIDY, MICHELLE HELTON AND CHRISTINE FOH RECEIVED PERFORMANCE BASED INCENTIVES EARNED IN FISCAL YEAR 2020 AND PAID IN CALENDAR YEAR 2020. PART II, COLUMN (B) (III): SUPPLEMENTAL COMPENSATION INFORMATION: OTHER REPORTABLE COMPENSATION DONNA MCCULLOUGH'S OTHER REPORTABLE COMPENSATION INCLUDES A RETENTION INCENTIVE ACCRUAL OF $100,000 WHICH WAS PAID IN CALENDAR YEAR 2020 AND WAS TIED TO SPECIFIC MULTI-YEAR VESTING REQUIREMENTS THROUGH JANUARY 31, 2020, PAYABLE IN 2020. THE RETENTION PAYMENT WAS MADE IN CALENDAR YEAR 2020. HARRY JOHNS AND RICHARD HOVLAND RECEIVE A BASIC LIFE INSURANCE BENEFIT OF ONE TIMES THE ANNUAL SALARY. THE AMOUNT REPRESENTED IN THIS SECTION IS IMPUTED INCOME FOR THE GROUP TERM LIFE BENEFIT. JOANNE PIKE, DONNA MCCULLOUGH, ROBERT EGGE, MARIA CARRILLO, GLENDA BERRY, KENANN CASSIDY, MICHELLE HELTON AND CHRISTINE FOH ALSO RECEIVE THE LIFE INSURANCE BENEFIT. HARRY JOHNS, RICHARD HOVLAND, JOANNE PIKE, KENANN CASSIDY, AND CHRISTINE FOH HAVE ADDITIONAL IMPUTED INCOME FOR VOLUNTARY ELECTIONS UNDER THE GROUP DISABILITY PLAN. PART II, COLUMN (C): SUPPLEMENTAL COMPENSATION INFORMATION: RETIREMENT AND OTHER DEFERRED COMPENSATION HARRY JOHNS - RETIREMENT AND OTHER DEFERRED COMPENSATION INCLUDES EMPLOYER CONTRIBUTIONS TO A QUALIFIED BROAD-BASED 401(K) RETIREMENT PLAN - $24,459. RICHARD HOVLAND - RETIREMENT AND OTHER DEFERRED COMPENSATION INCLUDES EMPLOYER CONTRIBUTIONS TO A QUALIFIED 401(K) RETIREMENT PLAN - $24,728. JOANNE PIKE, DONNA MCCULLOUGH, ROBERT EGGE, MARIA CARRILLO, GLENDA BERRY, KENANN CASSIDY, MICHELLE HELTON AND CHRISTINE FOH - RETIREMENT AND OTHER DEFERRED COMPENSATION INCLUDES EMPLOYER CONTRIBUTIONS TO A QUALIFIED 401(K) RETIREMENT PLAN. PART II, COLUMN (D): SUPPLEMENTAL COMPENSATION INFORMATION: NONTAXABLE BENEFITS HARRY JOHNS - NON-TAXABLE BENEFITS OF $26,787 INCLUDE EMPLOYER CONTRIBUTIONS TO MEDICAL, DENTAL, BASIC LIFE INSURANCE, SHORT AND LONG-TERM DISABILITY, AND LONG-TERM CARE INSURANCE BASED ON HIS PERSONAL ELECTIONS FOR CALENDAR YEAR 2020 THROUGH THE BENEFIT OFFERINGS AVAILABLE TO ALL OTHER BENEFITS-ELIGIBLE EMPLOYEES AT OUR ORGANIZATION. THE AMOUNTS REPRESENTED FOR RICHARD HOVLAND, JOANNE PIKE, DONNA MCCULLOUGH, ROBERT EGGE, MARIA CARRILLO, GLENDA BERRY, KENANN CASSIDY, MICHELLE HELTON AND CHRISTINE FOH REPRESENT COMPANY CONTRIBUTIONS TO THE MEDICAL, DENTAL, BASIC LIFE INSURANCE, SHORT AND LONG-TERM DISABILITY, AND LONG-TERM CARE INSURANCE BASED ON INDIVIDUAL ELECTIONS. X 904 6932028 FMV X NON GALA-RLTD 72 444676 FMV X FUNDRAISING 26 191622 FMV X GALA-RELATED 44 158765 FMV X RAFFLE 3 8150 FMV 0 1 1 PART I, LINE 25 AND LINE 32B: THIRD PARTY ASSISTANCE OF NONCASH CONTRIBUTIONS LINE 25 - THE ALZHEIMER'S ASSOCIATION RECEIVES VARIOUS NONCASH CONTRIBUTIONS FOR THEIR FUNDRAISING EVENTS. THESE ITEMS INCLUDE SPORTING TICKETS, JEWELRY, CONCERT TICKETS, DINNERS AND VARIOUS OTHER PACKAGES. LINE 32B: A THIRD PARTY RECEIVES DIRECTLY, SELLS AND REMITS PROCEEDS FROM AUTOMOBILE SALES. PART I, COLUMN B: ALZHEIMER'S ASSOCIATION IS REPORTING THE DOLLAR AMOUNT OF NONCASH CONTRIBUTIONS AS WELL AS THE NUMBER OF ITEMS RECEIVED. FORM 990, PART III, LINE I, DESCRIPTION OF ORGANIZATION MISSION: (MISSION CONTINUED) THE ALZHEIMER'S ASSOCIATION LEADS THE WAY TO END ALZHEIMER'S AND ALL OTHER DEMENTIA - BY ACCELERATING GLOBAL RESEARCH, DRIVING RISK REDUCTION AND EARLY DETECTION, AND MAXIMIZING QUALITY CARE AND SUPPORT. THE VISION OF THE ALZHEIMER'S ASSOCIATION IS A WORLD WITHOUT ALZHEIMER'S AND ALL OTHER DEMENTIA. THE ALZHEIMER'S ASSOCIATION IS A VALUED RESOURCE FOR CAREGIVERS AND THOSE LIVING WITH THE DISEASE, OFFERING INFORMATION, EDUCATION AND SUPPORT. APPROXIMATELY 200 OFFICES ACROSS THE U.S. ARE DOING BUSINESS AS THE ALZHEIMER'S ASSOCIATION AND VARIOUS NAMES AS A COLLECTION OF 75 CHAPTERS WORKING TO ACCOMPLISH THE MISSION. THE ORGANIZATION IS HEADQUARTERED IN CHICAGO, AND HAS A PUBLIC POLICY OFFICE IN WASHINGTON, D.C. THE ALZHEIMER'S ASSOCIATION PROVIDES 24/7 CONSTITUENT SUPPORT IN OVER 170 LANGUAGES THROUGH THE USE OF A PROFESSIONAL LANGUAGE LINE 365 DAYS A YEAR (1-800-272-3900) AS WELL AS ON OUR WEBSITE, ALZ.ORG*. AS THE LEADING VOLUNTARY HEALTH ORGANIZATION IN CARE, SUPPORT AND RESEARCH, SINCE AWARDING THE FIRST GRANTS IN 1982, THE ASSOCIATION HAS COMMITTED MORE THAN $475 MILLION TO MORE THAN 3,000 BEST-OF-FIELD GRANTS. AS A LEADER IN THE FIELD, THE ALZHEIMER'S ASSOCIATION FOSTERS COLLABORATION OF THE SCIENTIFIC COMMUNITY BY HOSTING THE LARGEST INTERNATIONAL CONFERENCE FOCUSING ON ALZHEIMER'S DISEASE RESEARCH IN THE WORLD. IN ADDITION, THE ALZHEIMER'S ASSOCIATION ADVOCATES FOR THE NEEDS AND RIGHTS OF PEOPLE WITH ALZHEIMER'S, THEIR FAMILIES AND CAREGIVERS, SPEAKING UP TO HELP ENCOURAGE CONGRESS TO TAKE ACTION IN THE FIGHT AGAINST THIS DISEASE, (INCLUDING THROUGH AN ANNUAL ADVOCACY FORUM IN WASHINGTON, D.C.) AND LEADS ADVOCACY EFFORTS IN EVERY STATE. CONCERN ABOUT ALZHEIMER'S DISEASE AND AWARENESS ABOUT THE ASSOCIATION ARE CRITICAL TO ACCELERATING PROGRESS. THE ALZHEIMER'S ASSOCIATION STRIVES TO MAKE MORE PEOPLE AWARE OF THE SERVICES AVAILABLE FOR THOSE FACING THIS DISEASE AND THE BENEFITS OF EARLY DETECTION. (MORE THAN 5 MILLION ALZHEIMER'S ASSOCIATION CONSTITUENTS HAVE SIGNED UP TO EDUCATE, ADVOCATE, DONATE, AND PARTICIPATE TO MOVE THIS CAUSE FORWARD). A DONOR-SUPPORTED ORGANIZATION, THE ALZHEIMER'S ASSOCIATION ALLOCATES ITS FUNDS IN AN ETHICAL AND RESPONSIBLE MANNER THAT EXCEEDS THE RIGOROUS STANDARDS OF AMERICA'S MOST EXPERIENCED CHARITY EVALUATOR, THE BETTER BUSINESS BUREAU WISE GIVING ALLIANCE. THE ASSOCIATION IS QUALIFIED TO USE THE "BBB TORCH LOGO AND A NATIONAL CHARITY SEAL ("SEAL"). * THESE ARE NAMES THAT ARE TRADEMARKS TO ALZHEIMER'S ASSOCIATION. FORM 990, PART III, LINE 4A, PROGRAM SERVICES: CONCERN AND AWARENESS - ALZHEIMER'S IS A PROGRESSIVE, DEGENERATIVE AND ULTIMATELY FATAL DISEASE. TOO FEW AMERICANS UNDERSTAND THE CURRENT AND FUTURE ECONOMIC IMPACT OF ALZHEIMER'S. ALREADY MORE THAN 6 MILLION AMERICANS ARE LIVING WITH ALZHEIMER'S AND OVER 11 MILLION PEOPLE ARE PROVIDING UP TO 15.3 BILLION HOURS OF UNPAID CARE AND SUPPORT. AND THIS MASSIVE GROUP IS IN NEED OF INFORMATION AND RESOURCES. THE ALZHEIMER'S ASSOCIATION HAS INVESTED IN EDUCATION CAMPAIGNS AND INITIATIVES TO INCREASE KNOWLEDGE ABOUT ALZHEIMER'S DISEASE AND AWARENESS OF THE ALZHEIMER'S ASSOCIATION COMMUNICATING OUR ROLE AS LEADERS OF THE CAUSE. KEY MESSAGES INCLUDE THE IMPORTANCE OF EARLY DETECTION, RESOURCES FOR PEOPLE WITH ALZHEIMER'S AND THEIR FAMILIES, AND THE SOCIETAL IMPACT OF THE DISEASE. MILLIONS OF CONSTITUENTS PARTICIPATED IN OUR PROGRAMS IN LOCAL COMMUNITIES AND ON-LINE. FORM 990, PART III, LINE 4B, PROGRAM SERVICES: RESEARCH - THE ALZHEIMER'S ASSOCIATION IS ON THE FOREFRONT OF THE ALZHEIMER'S SCIENTIFIC FIELD, GLOBALLY CONNECTING RESEARCHERS IN THE QUEST TO FIND METHODS OF TREATMENT, PREVENTION AND A CURE. THE ALZHEIMER'S ASSOCIATION IMPLEMENTS AN AGGRESSIVE GLOBAL RESEARCH AND SCIENCE PROGRAM STRATEGICALLY DESIGNED TO ACCELERATE PROGRESS BY FOSTERING INNOVATION, IDENTIFYING AND CLOSING CRITICAL KNOWLEDGE GAPS, DEVELOPING AND DISSEMINATING TOOLS, AND NURTURING SCIENTIFIC TALENT. THE ALZHEIMER'S ASSOCIATION HAS BEEN A CATALYST AND CONVENER FOR MORE THAN 30 YEARS. WHETHER FUNDING INNOVATIVE GRANTS TO HELP FURTHER TREATMENTS AND DISCOVERY, HOSTING THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE* (AAIC*), THE WORLD'S LARGEST GATHERING OF ALZHEIMER'S RESEARCHERS, OR LEADING ENDEAVORS LIKE THE WORLDWIDE ALZHEIMER'S DISEASE NEUROIMAGING INITIATIVE (WW-ADNI) TO ACCELERATE ADVANCES IN IMAGING, THE ALZHEIMER'S ASSOCIATION SEEKS TO FUND AND ADVANCE BEST-IN-CLASS RESEARCH AND WORKS WITH COLLABORATORS AROUND THE GLOBE FROM ALL SECTORS TO HASTEN THIS PROGRESS. * THESE ARE NAMES THAT ARE TRADEMARKS TO ALZHEIMER'S ASSOCIATION. FORM 990, PART VI, SECTION A, LINE 1 GOVERNING BODY: THE BOARD OF DIRECTORS OF THE ALZHEIMER'S ASSOCIATION IS THE ORGANIZATION'S GOVERNING BODY. THE BOARD HAS DELEGATED AUTHORITY TO ITS STANDING AND OTHER BUSINESS COMMITTEES AS DESCRIBED IN ARTICLE VII OF THE ORGANIZATIONAL BYLAWS. THE FOLLOWING EXCERPT FROM THE ASSOCIATION'S BYLAWS DISCUSS COMMITTEES OF THE BOARD OF DIRECTORS. COMMITTEES OF DIRECTORS: ALL COMMITTEE MEETINGS SHALL BE OPEN TO ATTENDANCE BY ALL DIRECTORS EXCEPT IN EXECUTIVE SESSION. ONLY COMMITTEE MEMBERS MAY VOTE ON COMMITTEE MATTERS. THE BOARD OF DIRECTORS SHALL HAVE THE FOLLOWING STANDING COMMITTEES: EXECUTIVE, FINANCE, GOVERNANCE AND NOMINATING, COMPENSATION, AUDIT AND MISSION OUTCOMES. EXECUTIVE COMMITTEE: THE EXECUTIVE COMMITTEE SHALL MANAGE THE BUSINESS AND PROPERTY OF THE ASSOCIATION IN BETWEEN MEETINGS OF THE BOARD OF DIRECTORS; PROVIDED, THAT THE EXECUTIVE COMMITTEE SHALL NOT TAKE ANY ACTION WHICH IS CONTRARY TO POLICIES OF THE ASSOCIATION AS ADOPTED BY THE BOARD OF DIRECTORS. THE EXECUTIVE COMMITTEE SHALL HAVE SUCH ADDITIONAL POWERS AS MAY BE PROVIDED BY LAW OR RESOLUTION OF THE BOARD OF DIRECTORS. THE EXECUTIVE COMMITTEE SHALL REPORT TO THE BOARD OF DIRECTORS AT EACH MEETING OF THE BOARD OF DIRECTORS AND REPORT EXECUTIVE COMMITTEE ACTIONS IN A TIMELY MANNER IN BETWEEN BOARD OF DIRECTORS MEETINGS. AT EACH OF ITS ANNUAL MEETINGS, THE BOARD OF DIRECTORS BY DULY ADOPTED RESOLUTION SHALL ELECT AN EXECUTIVE COMMITTEE CONSISTING OF NO FEWER THAN SEVEN NOR MORE THAN FIFTEEN DIRECTORS. THE CHAIR, CHAIR ELECT, VICE CHAIRS, SECRETARY, TREASURER, CHAIRS OF THE STANDING COMMITTEES, AND THE CHAIR OF THE MEDICAL AND SCIENTIFIC ADVISORY GROUP, SHALL BE MEMBERS OF THE EXECUTIVE COMMITTEE. THE CHAIR OF THE BOARD OF DIRECTORS SHALL BE THE CHAIR OF THE EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE MAY HOLD REGULAR MEETINGS MONTHLY OR AS IT MAY OTHERWISE DETERMINE, AT SUCH PLACE AND AT SUCH TIMES AND UPON SUCH NOTICE AS IT MAY DETERMINE. SPECIAL MEETINGS OF THE EXECUTIVE COMMITTEE MAY BE CALLED AT ANY TIME BY THE CHAIR OR BY ANY THREE OF ITS MEMBERS, BY NOTICE DELIVERED PERSONALLY OR BY MAIL, TELEPHONE, ELECTRONIC MAIL OR FACSIMILE AT LEAST SEVEN DAYS (OR AT LEAST 48 HOURS IN THE CASE OF TELEPHONIC MEETINGS) PRIOR TO THE MEETING. A MAJORITY OF THE CURRENTLY SERVING MEMBERS OF THE EXECUTIVE COMMITTEE SHALL CONSTITUTE A QUORUM FOR ALL PURPOSES. FINANCE COMMITTEE: THE FINANCE COMMITTEE SHALL CONSIST OF AT LEAST FIVE DIRECTORS AND SHALL BE CHAIRED BY THE TREASURER. THE FINANCE COMMITTEE SHALL OVERSEE AND REVIEW ALL FINANCIAL REPORTS, ACCOUNTING ACTIVITIES AND INVESTMENT DECISIONS OF THE ASSOCIATION AND ALSO SHALL PREPARE A PROJECTED BUDGET FOR EACH FISCAL YEAR TO BE PRESENTED TO THE BOARD OF DIRECTORS FOR APPROVAL. THE FINANCE COMMITTEE SHALL OVERSEE AND MAKE RECOMMENDATIONS TO THE BOARD OF DIRECTORS WITH RESPECT TO THE FINANCIAL OPERATION OF ALZHEIMER'S ASSOCIATION 401(K) SAVINGS PLAN AND THE APPOINTMENT OF FIDUCIARIES WITH RESPECT THERETO. GOVERNANCE AND NOMINATING COMMITTEE: AT EACH OF ITS ANNUAL MEETINGS, THE BOARD OF DIRECTORS BY DULY ADOPTED RESOLUTION SHALL ELECT A GOVERNANCE AND NOMINATING COMMITTEE CONSISTING OF NO FEWER THAN SEVEN NOR MORE THAN FIFTEEN INDIVIDUALS CURRENTLY SERVING AS A DIRECTOR. AT LEAST ONE-THIRD OF THE GOVERNANCE AND NOMINATING COMMITTEE SHALL BE DIRECTORS HAVING CHAPTER EXPERIENCE. THE GOVERNANCE AND NOMINATING COMMITTEE SHALL ASSIST THE BOARD IN ENSURING THE SUCCESSFUL GOVERNANCE OF THE ASSOCIATION THROUGH BOARD ASSESSMENT, RECRUITMENT, NOMINATIONS, ORIENTATION AND DEVELOPMENT. THE GOVERNANCE AND NOMINATING COMMITTEE SHALL NOMINATE CANDIDATES FOR DIRECTORS, OFFICERS AND MEMBERS OF THE EXECUTIVE COMMITTEE. THE GOVERNANCE AND NOMINATING COMMITTEE MAY NOMINATE CANDIDATES FOR HONORARY DIRECTOR AND ANY ADVISORY OR HONORARY COUNCILS, GROUPS OR COMMITTEES AND APPROVE THE CANDIDATES FOR MEDICAL AND SCIENTIFIC ADVISORY GROUP MEMBERSHIP. THE GOVERNANCE AND NOMINATING COMMITTEE ALSO SHALL PROVIDE INPUT TO THE CHAIR ON THE SELECTION OF VICE CHAIRS AND COMMITTEE CHAIRS. COMPENSATION COMMITTEE: THE COMPENSATION COMMITTEE SHALL BE RESPONSIBLE FOR REVIEWING AND APPROVING, SUBJECT TO FURTHER AND FINAL APPROVAL BY THE BOARD OF DIRECTORS, ALL FORMS OF COMPENSATION AND BENEFITS FOR THE PRESIDENT AND CHIEF EXECUTIVE OFFICER. THE COMPENSATION COMMITTEE SHALL CONDUCT ITS REVIEW AND APPROVAL OF THE PRESIDENT AND CHIEF EXECUTIVE OFFICER'S TOTAL COMPENSATION AND BENEFITS IN A MANNER INTENDED TO QUALIFY FOR THE REBUTTABLE PRESUMPTION OF REASONABLENESS UNDER SECTION 4958 OF THE INTERNAL REVENUE CODE OF 1986, AS AMENDED ("SECTION 4958"). THE COMPENSATION COMMITTEE ALSO SHALL BE RESPONSIBLE FOR REVIEWING AND APPROVING APPROPRIATE MARKET DATA, TO BE USED BY THE PRESIDENT AND CHIEF EXECUTIVE OFFICER TO SET OR ADJUST COMPENSATION OF ANY OTHER EXECUTIVE-LEVEL EMPLOYEE WHO COULD BE CONSIDERED TO BE IN A POSITION TO EXERCISE SUBSTANTIAL INFLUENCE OVER THE AFFAIRS OF THE ASSOCIATION WITHIN THE MEANING OF SECTION 4958. THE COMPENSATION COMMITTEE ALSO SHALL BE RESPONSIBLE FOR OVERSIGHT OF EXECUTIVE-LEVEL BENEFITS AND SUCCESSION PLANNING FOR KEY POSITIONS IN THE ASSOCIATION. AUDIT COMMITTEE: THE AUDIT COMMITTEE SHALL BE RESPONSIBLE FOR RECOMMENDING AN AUDITOR TO THE BOARD OF DIRECTORS AND SHALL OVERSEE THE ACTIVITIES OF ANY INTERNAL AUDITOR OF THE ASSOCIATION. THE AUDIT COMMITTEE SHALL SEE THAT AN ANNUAL AUDIT IS PREPARED BY AN INDEPENDENT FIRM OF CERTIFIED PUBLIC ACCOUNTANTS SELECTED BY THE BOARD OF DIRECTORS AND, UPON RECEIVING SUCH AUDITOR'S REPORT, THE AUDIT COMMITTEE SHALL PREVIEW THE AUDIT REPORT FOR SUBMISSION TO THE BOARD OF DIRECTORS EACH YEAR. THE AUDIT COMMITTEE SHALL REVIEW THE FINANCIAL REPORTS OF THE ASSOCIATION, ITS SYSTEM OF INTERNAL CONTROLS, AND THE AUDIT PROCESS. THE AUDIT COMMITTEE SHALL HAVE AT LEAST FIVE MEMBERS, ALL OF WHOM ARE MEMBERS OF THE BOARD OF DIRECTORS AND THE MAJORITY OF WHOM HAVE APPROPRIATE FINANCIAL EXPERTISE. AT LEAST ONE MEMBER OF THE AUDIT COMMITTEE SHALL MEET THE REQUIREMENT OF "AUDIT COMMITTEE FINANCIAL EXPERT" AS THEN DEFINED BY THE SECURITIES AND EXCHANGE COMMISSION. THE MAJORITY OF THE MEMBERS OF THE AUDIT COMMITTEE MAY NOT CONCURRENTLY SERVE ON THE FINANCE COMMITTEE AND THE TREASURER AND CHAIR OF THE FINANCE COMMITTEE MAY NOT SERVE CONCURRENTLY ON THE AUDIT COMMITTEE. MISSION OUTCOMES COMMITTEE: THE MISSION OUTCOMES COMMITTEE SHALL OVERSEE AND REVIEW PROGRESS AGAINST THE ALZHEIMER'S ASSOCIATION'S STRATEGIC PLAN'S PRIORITY ACTIVITIES AND SHALL SUPPORT AND FACILITATE BOARD OF DIRECTORS CONVERSATIONS THAT ARE FOCUSED ON MISSION DELIVERY AND THE APPROVED STRATEGIC PLAN. OTHER COMMITTEES: IN ADDITION TO THE STANDING COMMITTEES, OTHER COMMITTEES MAY BE DESIGNATED BY RESOLUTION ADOPTED BY A MAJORITY OF THE DIRECTORS PRESENT AT ANY MEETING. FORM 990, PART VI, SECTION B, LINE 11B FORM 990 REVIEW PROCESS THE ORGANIZATION UNDERGOES A THOROUGH REVIEW PROCESS BEFORE FILING THE RETURN. THE AUDIT COMMITTEE DISCUSSES AND REVIEWS THE FORM BEFORE IT IS PROVIDED TO THE OFFICERS AND FULL BOARD OF DIRECTORS. ALL OFFICERS AND THE FULL BOARD OF DIRECTORS ARE PROVIDED A COPY FOR THEIR REVIEW AND HAVE THE OPPORTUNITY TO COMMENT BEFORE THE FORM 990 IS FILED. FORM 990, PART VI, SECTION B, LINE 12C CONFLICT OF INTEREST POLICY MONITORING & ENFORCEMENT THE ALZHEIMER'S ASSOCIATION CONFLICT OF INTEREST POLICY IS DESCRIBED IN ARTICLE XII, SECTION 2 OF THE ORGANIZATIONAL BYLAWS. THE RESPONSIBILITY FOR DISCLOSING ANY KNOWN OR REASONABLY FORESEEABLE ACTUAL OR POTENTIAL CONFLICTS OF INTEREST SHALL BE DISCLOSED TO THE BOARD OF DIRECTORS OR ITS COMMITTEE DESIGNEE BY THE INTERESTED PERSON WHOSE INTERESTS ARE OR MAY APPEAR TO BE IN CONFLICT WITH THE ASSOCIATION. ALL INTERESTED PERSONS ARE REQUIRED TO FILE WITH THE ASSOCIATION A DISCLOSURE STATEMENT PRIOR TO SUCH INDIVIDUAL COMMENCING HIS OR HER SERVICE WITH THE ASSOCIATION AND AT SUCH TIME AND IN SUCH MANNER AS MAY BE PROVIDED IN GUIDELINES ADOPTED BY THE BOARD OF DIRECTORS. ALL INTERESTED PERSONS SERVING THE ASSOCIATION SHALL FILE DISCLOSURE STATEMENTS, FROM TIME TO TIME, AS MAY BE REQUIRED BY THE BOARD OF DIRECTORS, THE BYLAWS ARTICLE XII, SECTION 2 OR ANY OTHER BOARD POLICY, AND IN NO EVENT LESS OFTEN THAN ANNUALLY. INTERESTED PERSONS SHALL DISCLOSE ANY CONFLICT AND SHALL NOT VOTE ON A MATTER AND FURTHER IF REQUESTED BY THE CHAIR OR RESOLUTION OF THE BOARD SHALL LEAVE THE ROOM IN WHICH THE BOARD OR COMMITTEE IS MEETING AND SHALL NOT PARTICIPATE IN ANY DELIBERATION OR DECISION REGARDING THE MATTER UNDER CONSIDERATION. THE MINUTES SHALL REFLECT THAT THE CONFLICT OF INTEREST WAS DISCLOSED AND THE INTERESTED PERSON DID NOT PARTICIPATE IN ANY DISCUSSION OF THE MATTER AND DID NOT VOTE ON THE MATTER IN PERSON OR BY PROXY. WHEN ANY SUCH CONFLICT OF INTEREST IS RELEVANT TO A MATTER REQUIRING ACTION BY THE BOARD OF DIRECTORS OR ANY COMMITTEE OF THE BOARD, THE INTERESTED PERSON SHALL DISCLOSE SUCH CONFLICT TO THE BOARD OF DIRECTORS OR SUCH COMMITTEE AND SHALL NOT VOTE ON THE MATTER. FURTHER THE INTERESTED PERSON OR REPRESENTATIVE HAVING A CONFLICT IF REQUESTED BY THE CHAIR OR RESOLUTION OF THE BOARD SHALL LEAVE THE ROOM IN WHICH THE BOARD OR THE COMMITTEE IS MEETING AND SHALL NOT PARTICIPATE IN ANY DELIBERATION OR DECISION REGARDING THE MATTER UNDER CONSIDERATION. WHEN THERE IS A DOUBT AS TO WHETHER A CONFLICT OF INTEREST EXISTS, THE MATTER SHALL BE RESOLVED BY A VOTE OF THE BOARD OF DIRECTORS OR THE COMMITTEE, AS THE CASE MAY BE, EXCLUDING THE INTERESTED PERSON CONCERNING WHOM THE DOUBT HAS ARISEN. COPIES OF THE ASSOCIATION BYLAWS ARTICLE, INCLUDING THE CONFLICT OF INTEREST POLICY AND ANY RELATED ETHICAL POLICY OR GUIDELINES AS FROM TIME TO TIME ADOPTED OR AMENDED BY THE BOARD OF DIRECTORS, SHALL BE PRESENTED TO ALL INTERESTED PERSONS SERVING THE ASSOCIATION AT THE TIME OF ANY SUCH ADOPTION OR AMENDMENT AND IN NO EVENT LESS OFTEN THAN ANNUALLY; AND TO ALL INDIVIDUALS SEEKING TO SERVE THE ASSOCIATION AS AN INTERESTED PERSON PRIOR TO REQUESTING ANY SUCH INDIVIDUAL TO EXECUTE A CONFLICT OF INTEREST DISCLOSURE STATEMENT. FORM 990, PART VI, SECTION B, LINE 15 PROCESS FOR DETERMINING COMPENSATION COMPENSATION IS ESTABLISHED FOR THE CEO BY THE COMPENSATION COMMITTEE AND THE EXECUTIVE COMMITTEE AFTER A THOROUGH SALARY/MARKET REVIEW CONDUCTED BY OUTSIDE COMPENSATION CONSULTANTS. FOR THE CEO POSITION, THE GATHERING OF RELEVANT COMPARABILITY DATA FROM INDEPENDENT SOURCES OCCURRED IN 2020. THE PROCESS WAS CONDUCTED IN A MANNER INTENDED TO QUALIFY FOR THE REBUTTABLE PRESUMPTION OF REASONABLENESS UNDER THE INTERMEDIATE SANCTIONS RULES. AS TO THE MEMBERS OF THE SENIOR MANAGEMENT TEAM OTHER THAN THE CEO, ANNUALLY UPDATED MARKET DATA IS ALSO PROVIDED BY THE OUTSIDE COMPENSATION CONSULTANT, SO THAT THE UPDATED MARKET DATA CAN BE USED IN SETTING REASONABLE COMPENSATION FOR EACH MEMBER OF THE SENIOR MANAGEMENT TEAM. EACH YEAR THE COMPENSATION COMMITTEE EVALUATES THE CEO'S PERFORMANCE THROUGH A ROBUST ASSESSMENT PROCESS WHICH INCLUDES MARKET DATA COLLECTION, INTERVIEWS AND PERFORMANCE EVALUATION COMPARING RESULTS TO GOALS. THE COMMITTEE AND CHAIR OF THE BOARD USE THIS DATA TO DETERMINE INCENTIVE COMPENSATION ELIGIBILITY. THE SENIOR STAFF HAS A COMPREHENSIVE PERFORMANCE EVALUATION AND COMPENSATION REVIEW DONE AT THE END OF EACH FISCAL YEAR. THESE INCLUDE A SELF-ASSESSMENT AND EVALUATION BY THE CEO. UPDATED MARKET DATA FOR USE IN SETTING REASONABLE COMPENSATION IS PROVIDED BY A NATIONAL COMPENSATION CONSULTING FIRM TO THE COMPENSATION COMMITTEE FOR CONFIRMATION OF REASONABLENESS USING A PROCESS DESIGNED TO QUALIFY FOR THE REBUTTABLE PRESUMPTION OF REASONABLENESS (INCLUDING CONTEMPORANEOUS DOCUMENTATION IN THE COMMITTEE'S MINUTES). FOR FISCAL YEAR 2021, THE SALARY AND TOTAL COMPENSATION PACKAGE OF THE CEO WAS BENCHMARKED BY SULLIVAN COTTER. THE COMPENSATION COMMITTEE'S REVIEW AND APPROVAL PROCESS IS THOROUGHLY AND CONTEMPORANEOUSLY DOCUMENTED IN THE COMMITTEE'S MEETING MINUTES. FORM 990, PART VI, SECTION C, LINE 18 HOW DOCUMENTS ARE MADE AVAILABLE TO THE PUBLIC THE ORGANIZATION MAKES ITS FORM 990 AVAILABLE TO THE GENERAL PUBLIC BY POSTING ON THE WEBSITE AT WWW.ALZ.ORG AND UPON REQUEST. THE ORGANIZATION MAKES ITS FORM 1023 AVAILABLE TO THE GENERAL PUBLIC UPON REQUEST. FORM 990, PART VI, SECTION C, LINE 19 HOW DOCUMENTS ARE MADE AVAILABLE TO THE PUBLIC THE ORGANIZATION'S AUDITED FINANCIAL STATEMENTS ARE MADE AVAILABLE TO THE GENERAL PUBLIC BY POSTING ON THE ORGANIZATION'S WEBSITE AT WWW.ALZ.ORG AND UPON REQUEST. THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY AVAILABLE TO THE GENERAL PUBLIC UPON REQUEST. GENERAL NOTE EFFECTIVE JULY 1, 2016, ONE CHAPTER DISSOLVED AND 46 CHAPTERS MERGED WITH THE ASSOCIATION TO CREATE A UNITED ALZHEIMER'S ASSOCIATION. TOTAL ASSETS ACQUIRED FROM THE 47 CHAPTERS WERE APPROXIMATELY $152,004,000 AND NET ASSETS ACQUIRED WERE APPROXIMATELY $130,859,000. THE ASSOCIATION OVERSEES THE OPERATIONS AND ACTIVITIES FOR 75 CHAPTERS TO FACILITATE STRATEGIC ALIGNMENT, DELIVER ON THE OVERARCHING ASSOCIATION-WIDE STRATEGIC OBJECTIVES AND PRIORITY ACTIVITIES, AND TO ENSURE COVERAGE FOR ALL GEOGRAPHIC TERRITORIES. FORM 990, PART XI, LINE 9: CHANGE IN PERPETUAL TRUST 5,453,372. CHANGE IN SPLIT INTEREST 453,005. BAD DEBT EXPENSE -3,020,273. REIMBURSEMENT OF RENTAL EXPENSES 24,185. ALZHEIMER'S IMPACT MOVEMENT (AIM) 225 N MICHIGAN AVE FL 17 CHICAGO IL 60601 271961435 SOCIAL WELFARE IL 501(C)(4) ALZ ASSOC 1 ALZHEIMER'S ASSOCIATION INTERNATIONAL 181 BAY ST BROOKFIELD PL 2100 TORONTO ONTARIO CA M5J2T3 999999999 PUBLIC FOUNDATION CA 501(C)(3) ALZ ASSOC 1 COALITION OF NY STATE ALZ ASSN CHAPS INC 4 PINE WEST PLAZA 405 ALBANY NY 12205 134076596 PUBLIC CHARITY NY 501(C)(3) LINE 7 ALZ ASSOC 1 0 1 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 ALZHEIMER'S IMPACT MOVEMENT B 6649099 FMV ALZHEIMER'S IMPACT MOVEMENT N 224120 FMV ALZHEIMER'S IMPACT MOVEMENT O 3747288 FMV COALITION OF NY STATE ALZ ASSN CHAPS INC O 198338 FMV PART V, LINE 2: AMOUNT INVOLVED IN RELATIONSHIP THE ALZHEIMER'S ASSOCIATION GRANTED FUNDS TO ALZHEIMER'S IMPACT MOVEMENT (AIM) FOR PUBLIC POLICY DIVISION ACTIVITIES IN FISCAL YEAR 2021 TO SUPPORT PRIORITIES IDENTIFIED IN THE ALZHEIMER'S ASSOCIATION'S STRATEGIC PLAN. THIS GRANT IS RESTRICTED TO THE FOLLOWING 501(C)(3) ACTIVITIES AND THE ANCILLARY ACTIVITIES NECESSARY TO ACCOMPLISH SPECIFIC GOALS INCLUDING: IMPLEMENTATION OF THE NATIONAL ALZHEIMER'S PROJECT ACT (RECOGNIZING THIS GROWING ALZHEIMER'S CRISIS, CONGRESS UNANIMOUSLY PASSED AND THE PRESIDENT SIGNED INTO LAW THE NATIONAL ALZHEIMER'S PROJECT ACT - NAPA); INCREASING THE COMMITMENT TO ALZHEIMER'S RESEARCH; EXPANDING EDUCATION EFFORTS AND CAREGIVER SUPPORT SERVICES; EXPANDING DIAGNOSIS AND PLANNING.